Johnny Brooks, Ph.D. - Publications

Affiliations: 
2014 Public Policy and Administration Walden University, Minneapolis, MN, United States 
Area:
Criminology and Penology, Public and Social Welfare, African American Studies, Gender Studies

0/403 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2021 Azad AD, Yilmaz M, Bozkurt S, Brooks JD, Blayney DW, Hernandez-Boussard T. Diverse patient trajectories during cytotoxic chemotherapy: Capturing longitudinal patient-reported outcomes. Cancer Medicine. PMID 34254459 DOI: 10.1002/cam4.4124  0.01
2021 Hsu EC, Shen M, Aslan M, Liu S, Kumar M, Garcia-Marques F, Nguyen HM, Nolley R, Pitteri SJ, Corey E, Brooks JD, Stoyanova T. MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. Scientific Reports. 11: 13305. PMID 34172788 DOI: 10.1038/s41598-021-92552-x  0.01
2021 Soerensen SJC, Thomas IC, Schmidt B, Daskivich T, Skolarus TA, Jackson C, Osborne TF, Chertow GM, Brooks JD, Rehkopf D, Leppert JT. Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021. Urology. PMID 34139251 DOI: 10.1016/j.urology.2021.05.056  0.01
2021 Liu S, Garcia-Marques F, Zhang CA, Lee JJ, Nolley R, Shen M, Hsu EC, Aslan M, Koul K, Pitteri SJ, Brooks JD, Stoyanova T. Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay. Scientific Reports. 11: 7612. PMID 33828176 DOI: 10.1038/s41598-021-87155-5  0.01
2021 Seetharaman A, Bhattacharya I, Chen LC, Kunder CA, Shao W, Soerensen SJC, Wang JB, Teslovich NC, Fan RE, Ghanouni P, Brooks JD, To'o KJ, Sonn GA, Rusu M. Automated Detection of Aggressive and Indolent Prostate Cancer on Magnetic Resonance Imaging. Medical Physics. PMID 33760269 DOI: 10.1002/mp.14855  0.01
2021 Kim JH, Jeong IG, Khandwala YS, Hernandez-Boussard T, Brooks JD, Chung BI. Prevalence of Postprostatectomy Incontinence Requiring Anti-incontinence Surgery After Radical Prostatectomy for Prostate Cancer: A Retrospective Population-Based Analysis. International Neurourology Journal. PMID 33705635 DOI: 10.5213/inj.2040296.148  0.01
2021 Xie J, Rice MA, Chen Z, Cheng Y, Hsu EC, Chen M, Song G, Cui L, Zhou K, Castillo JB, Zhang CA, Shen B, Chin FT, Kunder CA, Brooks JD, et al. In vivo imaging of methionine aminopeptidase II for prostate cancer risk stratification. Cancer Research. PMID 33637565 DOI: 10.1158/0008-5472.CAN-20-2969  0.01
2021 Sood RR, Shao W, Kunder C, Teslovich NC, Wang JB, Soerensen SJC, Madhuripan N, Jawahar A, Brooks JD, Ghanouni P, Fan RE, Sonn GA, Rusu M. 3D Registration of pre-surgical prostate MRI and histopathology images via super-resolution volume reconstruction. Medical Image Analysis. 69: 101957. PMID 33550008 DOI: 10.1016/j.media.2021.101957  0.01
2021 Ghoochani A, Hsu EC, Aslan M, Rice MA, Nguyen HM, Brooks JD, Corey E, Paulmurugan R, Stoyanova T. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Research. PMID 33483372 DOI: 10.1158/0008-5472.CAN-20-3477  0.01
2021 Coquet J, Bievre N, Billaut V, Seneviratne M, Magnani CJ, Bozkurt S, Brooks JD, Hernandez-Boussard T. Assessment of a Clinical Trial-Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer. Jama Network Open. 4: e2031730. PMID 33481032 DOI: 10.1001/jamanetworkopen.2020.31730  0.01
2021 Magnani CJ, Bievre N, Baker LC, Brooks JD, Blayney DW, Hernandez-Boussard T. Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance. European Urology Open Science. 23: 20-29. PMID 33367287 DOI: 10.1016/j.euros.2020.11.004  0.01
2021 Peterson DJ, Ostberg NP, Bozkurt S, Brooks JD, Blayney DW, Hernandez-Boussard T. HSR21-068: Predicting Preventable Emergency Department Visits and Admissions After Chemotherapy Journal of the National Comprehensive Cancer Network. 19: HSR21-068. DOI: 10.6004/JNCCN.2020.7772  0.01
2020 Shao W, Banh L, Kunder CA, Fan RE, Soerensen SJC, Wang JB, Teslovich NC, Madhuripan N, Jawahar A, Ghanouni P, Brooks JD, Sonn GA, Rusu M. ProsRegNet: A deep learning framework for registration of MRI and histopathology images of the prostate. Medical Image Analysis. 68: 101919. PMID 33385701 DOI: 10.1016/j.media.2020.101919  0.01
2020 Liu S, Shen M, Hsu EC, Zhang CA, Garcia-Marques F, Nolley R, Koul K, Rice MA, Aslan M, Pitteri SJ, Massie C, George A, Brooks JD, Gnanapragasam VJ, Stoyanova T. Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer. British Journal of Cancer. PMID 33288843 DOI: 10.1038/s41416-020-01200-0  0.01
2020 Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Velaer KN, Goldstein MK, Wagner TH, Chertow GM, Brooks JD, Patel CJ, Desai M, Leppert JT. Laboratory-wide association study of survival with prostate cancer. Cancer. PMID 33237577 DOI: 10.1002/cncr.33341  0.01
2020 Bozkurt S, Paul R, Coquet J, Sun R, Banerjee I, Brooks JD, Hernandez-Boussard T. Phenotyping severity of patient-centered outcomes using clinical notes: A prostate cancer use case. Learning Health Systems. 4: e10237. PMID 33083539 DOI: 10.1002/lrh2.10237  0.01
2020 Magnani CJ, Steinberg JR, Harmange CI, Zhang X, Driscoll C, Bell A, Larson J, You JG, Weeks BT, Turner BE, Brooks JD. Clinical Trial Outcomes in Urology: Assessing Early Discontinuation, Results Reporting, and Publication in ClinicalTrials.Gov Registrations 2007-2019. The Journal of Urology. 101097JU000000000000. PMID 33079618 DOI: 10.1097/JU.0000000000001432  0.01
2020 Huynh KM, Wong A, Wu B, Horschman M, Zhao H, Brooks JD. Sprr2f protects against renal injury by decreasing the level of reactive oxygen species in female mice. American Journal of Physiology. Renal Physiology. PMID 33017192 DOI: 10.1152/ajprenal.00318.2020  0.01
2020 Brennan K, Metzner TJ, Kao CS, Massie CE, Stewart GD, Haile RW, Brooks JD, Hitchins MP, Leppert JT, Gevaert O. Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma. Jco Precision Oncology. 4. PMID 33015531 DOI: 10.1200/PO.20.00015  0.01
2020 Coquet J, Blayney DW, Brooks JD, Hernandez-Boussard T. Association between patient-initiated emails and overall 2-year survival in cancer patients undergoing chemotherapy: Evidence from the real-world setting. Cancer Medicine. PMID 32986931 DOI: 10.1002/cam4.3483  0.01
2020 Vilson FL, Li S, Brooks JD, Eisenberg ML. Sudden PSA rise to ≥20 ng/ml and prostate cancer diagnosis in the United States: A population-based study. The Prostate. PMID 32956488 DOI: 10.1002/pros.24075  0.01
2020 Crump C, Stattin P, Brooks JD, Stocks T, Sundquist J, Sieh W, Sundquist K. Early-Life Cardiorespiratory Fitness and Long-Term Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32856610 DOI: 10.1158/1055-9965.EPI-20-0535  0.01
2020 Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, et al. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. Jama Oncology. e203187. PMID 32852532 DOI: 10.1001/Jamaoncol.2020.3187  0.01
2020 Xiao Y, Thakkar KN, Zhao H, Broughton J, Li Y, Seoane JA, Diep AN, Metzner TJ, von Eyben R, Dill DL, Brooks JD, Curtis C, Leppert JT, Ye J, Peehl DM, et al. The mA RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America. PMID 32817424 DOI: 10.1073/Pnas.2000516117  0.01
2020 Winther MD, Kristensen G, Stroomberg HV, Berg KD, Toft BG, Brooks JD, Brasso K, Røder MA. AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy. Diagnostics (Basel, Switzerland). 10. PMID 32726925 DOI: 10.3390/diagnostics10080520  0.01
2020 Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Daskivich TJ, Skolarus TA, Shelton JB, Makarov DV, Bergman J, Bang CK, Goldstein MK, Wagner TH, Brooks JD, Desai M, Leppert JT. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration. Urologic Oncology. PMID 32674954 DOI: 10.1016/j.urolonc.2020.05.015  0.01
2020 Rusu M, Shao W, Kunder CA, Wang JB, Soerensen SJC, Teslovich NC, Sood RR, Chen LC, Fan RE, Ghanouni P, Brooks JD, Sonn GA. Registration of pre-surgical MRI and histopathology images from radical prostatectomy via RAPSODI. Medical Physics. PMID 32564359 DOI: 10.1002/Mp.14337  0.01
2020 DeRouen MC, McKinley M, Shah SA, Borno HT, Aoki R, Lichtensztajn DY, Leppert JT, Brooks JD, Chung BI, Gomez SL, Cheng I. Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California. Cancer Causes & Control : Ccc. PMID 32440828 DOI: 10.1007/S10552-020-01311-2  0.01
2020 Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, et al. Magnetic Resonance Imaging for the Detection of High-Grade Cancer in the Canary Prostate Active Surveillance Study. The Journal of Urology. 101097JU000000000000. PMID 32343189 DOI: 10.1097/Ju.0000000000001088  0.01
2020 Li K, Banerjee I, Magnani CJ, Blayney DW, Brooks JD, Hernandez-Boussard T. Clinical Documentation to Predict Factors Associated with Urinary Incontinence Following Prostatectomy for Prostate Cancer. Research and Reports in Urology. 12: 7-14. PMID 32158720 DOI: 10.2147/RRU.S234178  0.01
2020 Lin DW, Zheng Y, McKenney JK, Brown MD, Lu R, Crager M, Boyer H, Tretiakova M, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Kolb S, Liss M, Morgan TM, et al. 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902267. PMID 32130059 DOI: 10.1200/Jco.19.02267  0.01
2020 Sun AJ, Thomas IC, Velaer KN, Ganesan C, Song S, Pao AC, Wagner TH, Brooks JD, Chertow GM, Leppert JT. The Urine Albumin-Creatinine Ratio and Kidney Function after Nephrectomy. The Journal of Urology. 101097JU000000000000. PMID 32125227 DOI: 10.1097/JU.0000000000001005  0.01
2020 Hernandez-Boussard T, Blayney DW, Brooks JD. Leveraging Digital Data to Inform and Improve Quality Cancer Care. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32066619 DOI: 10.1158/1055-9965.EPI-19-0873  0.01
2020 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, et al. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 31951502 DOI: 10.1097/JU.0000000000000621.02  0.01
2020 Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, ... ... Brooks JD, et al. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. Proceedings of the National Academy of Sciences of the United States of America. PMID 31932422 DOI: 10.1073/Pnas.1905384117  0.01
2020 Eminaga O, Abbas M, Semjonow A, Brooks JD, Rubin D. Determination of biologic and prognostic feature scores from whole slide histology images using deep learning. Journal of Clinical Oncology. 38: e17527-e17527. DOI: 10.1200/jco.2020.38.15_suppl.e17527  0.01
2020 Eminaga O, Loening A, Lu A, Brooks JD, Rubin D. Detection of prostate cancer and determination of its significance using explainable artificial intelligence. Journal of Clinical Oncology. 38: 5555-5555. DOI: 10.1200/Jco.2020.38.15_Suppl.5555  0.01
2020 Blayney DW, Azad A, Yilmaz M, Bozkurt S, Brooks JD, Hernandez-Boussard T. Four distinct patient-reported outcome (PRO) trajectories in longitudinal responses collected before, during, and after chemotherapy. Journal of Clinical Oncology. 38: 2012-2012. DOI: 10.1200/jco.2020.38.15_suppl.2012  0.01
2020 Lichtensztajn DY, Hofer BM, Leppert JT, Brooks JD, Chung BI, Shah SA, DeRouen MC, Gomez SL, Cheng I. Abstract PR16: Association of renal cell carcinoma subtypes with race/ethnicity and comorbid medical conditions Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Pr16  0.01
2020 DeRouen MC, McKinley M, Shah SA, Borno HT, Aoki R, Lichtensztajn DY, Leppert JT, Brooks JD, Chung B, Gomez SL, Cheng I. Abstract C053: Testicular cancer in Hispanics: Incidence of subtypes over time according to neighborhood sociodemographic factors in California Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C053  0.01
2020 Waisman Malaret* AJ, Zhu K, Zheng Y, Newcomb L, Chang P, Olugbade KO, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, et al. PD62-09 EVALUATING THE OUTCOMES OF ACTIVE SURVEILLANCE IN GLEASON GRADE GROUP 2 PROSTATE CANCER The Journal of Urology. 203: e1289. DOI: 10.1097/Ju.0000000000000979.09  0.01
2020 Magnani* CJ, Bievre N, Erdogdu B, Baker LC, Brooks JD, Hernandez-Boussard T. MP23-12 MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AND RECLASSIFICATION FROM ACTIVE SURVEILLANCE Journal of Urology. 203. DOI: 10.1097/JU.0000000000000856.012  0.01
2019 Vijayalakshmi K, Shankar V, Bain RM, Nolley R, Sonn GA, Kao CS, Zhao H, Tibshirani R, Zare RN, Brooks JD. Identification of Diagnostic Metabolic Signatures in Clear Cell Renal Cell Carcinoma Using Mass Spectrometry Imaging. International Journal of Cancer. PMID 31863456 DOI: 10.1002/Ijc.32843  0.01
2019 Gong X, Zhao H, Saar M, Peehl DM, Brooks JD. miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma. Kidney Cancer. 3: 119-132. PMID 31763513 DOI: 10.3233/KCA-190051  0.01
2019 Brooks JD. Editorial Comment. The Journal of Urology. 10109701JU0000612612. PMID 31674872 DOI: 10.1097/01.JU.0000612612.70338.13  0.01
2019 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, et al. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS). The Journal of Urology. 101097JU000000000000. PMID 31651227 DOI: 10.1097/Ju.0000000000000621  0.01
2019 Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma. Cancer Research. PMID 31585940 DOI: 10.1158/0008-5472.Can-19-1366  0.01
2019 Gori D, Banerjee I, Chung BI, Ferrari M, Rucci P, Blayney DW, Brooks JD, Hernandez-Boussard T. Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy. Egems (Washington, Dc). 7: 43. PMID 31497615 DOI: 10.5334/egems.297  0.01
2019 Kothapalli SR, Sonn GA, Choe JW, Nikoozadeh A, Bhuyan A, Park KK, Cristman P, Fan R, Moini A, Lee BC, Wu J, Carver TE, Trivedi D, Shiiba L, Steinberg I, ... ... Brooks JD, et al. Simultaneous transrectal ultrasound and photoacoustic human prostate imaging. Science Translational Medicine. 11. PMID 31462508 DOI: 10.1126/Scitranslmed.Aav2169  0.01
2019 Lenain R, Seneviratne MG, Bozkurt S, Blayney DW, Brooks JD, Hernandez-Boussard T. Machine Learning Approaches for Extracting Stage from Pathology Reports in Prostate Cancer. Studies in Health Technology and Informatics. 264: 1522-1523. PMID 31438212 DOI: 10.3233/SHTI190515  0.01
2019 Xu L, Lee JR, Hao S, Ling XB, Brooks JD, Wang SX, Gambhir SS. Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies. Plos One. 14: e0221051. PMID 31404106 DOI: 10.1371/Journal.Pone.0221051  0.01
2019 Banerjee S, Wong AC, Yan X, Wu B, Zhao H, Tibshirani RJ, Zare RN, Brooks JD. Early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry. Scientific Reports. 9: 11007. PMID 31358807 DOI: 10.1038/S41598-019-47396-X  0.01
2019 Kristensen G, Berg KD, Toft BG, Stroomberg HV, Nolley R, Brooks JD, Brasso K, Roder MA. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis. Journal of Clinical Pathology. PMID 31331953 DOI: 10.1136/jclinpath-2019-205940  0.01
2019 Bozkurt S, Kan KM, Ferrari MK, Rubin DL, Blayney DW, Hernandez-Boussard T, Brooks JD. Is it possible to automatically assess pretreatment digital rectal examination documentation using natural language processing? A single-centre retrospective study. Bmj Open. 9: e027182. PMID 31324681 DOI: 10.1136/bmjopen-2018-027182  0.01
2019 Magnani CJ, Li K, Seto T, McDonald KM, Blayney DW, Brooks JD, Hernandez-Boussard T. PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 795-803. PMID 31319390 DOI: 10.6004/jnccn.2018.7274  0.01
2019 Wang NN, Teslovich NC, Fan RE, Ghanouni P, Leppert JT, Brooks JD, Ahmadi S, Sonn GA. Applying the PRECISION approach in biopsy naïve and previously negative prostate biopsy patients. Urologic Oncology. PMID 31151788 DOI: 10.1016/J.Urolonc.2019.05.002  0.01
2019 Middleton LW, Shen Z, Varma S, Pollack AS, Gong X, Zhu S, Zhu C, Foley JW, Vennam S, Sweeney RT, Tu K, Biscocho J, Eminaga O, Nolley R, Tibshirani R, ... Brooks JD, et al. Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis. Jci Insight. 5. PMID 31094703 DOI: 10.1172/Jci.Insight.129749  0.01
2019 Banerjee I, Li K, Seneviratne M, Ferrari M, Seto T, Brooks JD, Rubin DL, Hemandez-Boussard T. Weakly supervised natural language processing for assessing patient-centered outcome following prostate cancer treatment. Jamia Open. 2: 150-159. PMID 31032481 DOI: 10.1093/jamiaopen/ooy057  0.01
2019 Coquet J, Bozkurt S, Kan KM, Ferrari MK, Blayney DW, Brooks JD, Hernandez-Boussard T. Comparison of Orthogonal NLP Methods for Clinical Phenotyping and Assessment of Bone Scan Utilization among Prostate Cancer Patients. Journal of Biomedical Informatics. 103184. PMID 31014980 DOI: 10.1016/j.jbi.2019.103184  0.01
2019 Davenport MT, Zhang CA, Leppert JT, Brooks JD, Eisenberg ML. Vasectomy and the risk of prostate cancer in a prospective US Cohort: Data from the NIH-AARP Diet and Health Study. Andrology. PMID 30714352 DOI: 10.1111/andr.12570  0.01
2019 Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, et al. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). Prostate Cancer and Prostatic Diseases. PMID 30664734 DOI: 10.1038/S41391-018-0124-Z  0.01
2019 Lin DW, Zheng Y, McKenney J, Brown M, Lu R, Crager M, Boyer H, Brooks JD, Dash A, Fabrizio M, Gleave M, Liss MA, Morgan TM, Thompson IM, Wagner A, et al. Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS). Journal of Clinical Oncology. 37: 262-262. DOI: 10.1200/Jco.2019.37.7_Suppl.262  0.01
2019 Chen* L, Bien N, Fan R, Cheong R, Rajpurkar P, Thong A, Wang N, Ahmadi S, Rusu M, Brooks J, Ng A, Sonn G. PD60-05 AUTOMATED DETECTION OF PROSTATE CANCER ON MULTIPARAMETRIC MRI USING DEEP NEURAL NETWORKS TRAINED ON SPATIAL COORDINATES AND PATHOLOGY OF BIOPSY CORES Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557214.92207.3F  0.01
2019 Schenk JM, Faino AV, Newcomb* LF, Brooks JD, Carroll PR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PD50-10 AFRICAN AMERICAN RACE IS NOT ASSOCIATED WITH RECLASSIFICATION DURING ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 201. DOI: 10.1097/01.ju.0000556885.55209.5f  0.01
2019 Liss* M, Garcia M, Zheng Y, Newcomb L, Filson C, Boyer H, Brooks J, Carroll P, Gleave M, Martin F, Morgan T, Nelson P, Wagner A, Thompson I, Lin D. PD50-01 ASSESSMENT OF MRI PERFORMANCE IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556876.83918.Db  0.01
2019 Newcomb* L, Zheng Y, Faino A, Schenk J, Brooks J, Cooperberg M, Dash A, Gleave M, Liss M, Martin F, Morgan T, Nelson P, Wagner A, Thompson I, Lin D. MP48-15 EVALUATION OF POTENTIAL BIAS IN RISK FACTOR ASSESSMENT IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556449.83860.B5  0.01
2019 Sohlberg* E, Thomas I, Daskivich T, Skolarus T, Shelton J, Makarov D, Bergman J, Bang C, Kapphahn K, Yang J, Brooks JD, Desai M, Leppert JT. MP41-19 OPTIMIZING LIFE EXPECTANCY ESTIMATES FOR VHA PATIENTS WITH PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.JU.0000556202.91852.ac  0.01
2019 Sun A, Thomas I, Ganesan C, Pao A, Wagner T, Brooks J, Chertow G, Leppert J. Mp31-12 The Albumin-Creatinine Ratio And Kidney Function Outcomes After Nephrectomy The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555849.78956.Ba  0.01
2018 Hoerner CR, Massoudi R, Metzner TJ, Stell L, O'Rourke JJ, Kong CS, Liliental JE, Brooks JD, Sabatti C, Leppert JT, Fan AC. Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma. European Urology Oncology. PMID 31412000 DOI: 10.1016/J.Euo.2018.09.011  0.01
2018 Wang NN, Fan RE, Leppert JT, Ghanouni P, Kunder CA, Brooks JD, Chung BI, Sonn GA. Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy. Research and Reports in Urology. 10: 233-235. PMID 30538970 DOI: 10.2147/Rru.S178064  0.01
2018 Seneviratne MG, Bozkurt S, Patel MI, Seto T, Brooks JD, Blayney DW, Kurian AW, Hernandez-Boussard T. Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer. Cancer. PMID 30512191 DOI: 10.1002/cncr.31895  0.01
2018 Lichtensztajn DY, Leppert JT, Brooks JD, Shah SA, Sieh W, Chung BI, Gomez SL, Cheng I. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1353-1360. PMID 30442735 DOI: 10.6004/Jnccn.2018.7060  0.01
2018 Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction. Journal of Pediatric Urology. PMID 30420258 DOI: 10.1016/j.jpurol.2018.10.007  0.01
2018 Gori D, Dulal R, Blayney DW, Brooks JD, Fantini MP, McDonald KM, Hernandez-Boussard T. Utilization of Prostate Cancer Quality Metrics for Research and Quality Improvement: A Structured Review. Joint Commission Journal On Quality and Patient Safety. PMID 30236510 DOI: 10.1016/j.jcjq.2018.06.004  0.01
2018 Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T. Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer. Egems (Washington, Dc). 6: 13. PMID 30094285 DOI: 10.5334/egems.234  0.01
2018 Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, et al. Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS). The Journal of Urology. PMID 30076904 DOI: 10.1016/J.Juro.2018.07.065  0.01
2018 Leppert JT, Brooks JD. Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.01.043. European Urology. PMID 30017399 DOI: 10.1016/j.eururo.2018.06.044  0.01
2018 Lasseigne BN, Brooks JD. The Role of DNA Methylation in Renal Cell Carcinoma. Molecular Diagnosis & Therapy. PMID 29777398 DOI: 10.1007/S40291-018-0337-9  0.01
2018 Helgstrand JT, Røder MA, Klemann N, Toft BG, Lichtensztajn DY, Brooks JD, Brasso K, Vainer B, Iversen P. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts. Cancer. PMID 29723398 DOI: 10.1002/cncr.31384  0.01
2018 Totten SM, Adusumilli R, Kullolli M, Tanimoto C, Brooks JD, Mallick P, Pitteri SJ. Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera. Scientific Reports. 8: 6509. PMID 29695737 DOI: 10.1038/S41598-018-24270-W  0.01
2018 Guo DP, Thomas IC, Mittakanti HR, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Sonn GA, Chung BI, Brooks JD, Leppert JT. The Research Implications of PSA Registry Errors: Data from the Veterans Health Administration. The Journal of Urology. PMID 29630980 DOI: 10.1016/j.juro.2018.03.127  0.01
2018 Wu B, Gong X, Kennedy WA, Brooks JD. Identification of transcripts associated with renal damage due to ureteral obstruction as candidate urinary biomarkers. American Journal of Physiology. Renal Physiology. PMID 29488389 DOI: 10.1152/ajprenal.00382.2017  0.01
2018 Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, ... ... Brooks JD, et al. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 9: 6550-6561. PMID 29464091 DOI: 10.18632/Oncotarget.23973  0.01
2018 Eminaga O, Li S, Baker LC, Brooks JD, Eisenberg ML. Male infertility is associated with altered treatment course of men with cancer. Andrology. PMID 29457365 DOI: 10.1111/andr.12472  0.01
2018 Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, et al. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. European Urology. PMID 29433975 DOI: 10.1016/J.Eururo.2018.01.017  0.01
2018 Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. European Urology. PMID 29433973 DOI: 10.1016/J.Eururo.2018.01.016  0.01
2018 Cooperberg MR, Faino AV, Newcomb LF, Carroll P, Kearns JT, Brooks JD, Fabrizio M, Gleave M, Morgan TM, Dash A, Nelson P, Thompson IM, Wagner A, Lin DW, Zheng Y. When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer. Journal of Clinical Oncology. 36: 140-140. DOI: 10.1200/Jco.2018.36.6_Suppl.140  0.01
2018 Li K, Magnani CJ, Bozkurt S, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T. Practice-based evidence for factors associated with urinary incontinence following prostate cancer care. Journal of Clinical Oncology. 36: 106-106. DOI: 10.1200/JCO.2018.36.6_SUPPL.106  0.01
2018 Xie J, Rice M, Cheng Y, Song G, Kunder C, Brooks JD, Stoyanova T, Rao J. Abstract B068: Methionine aminopeptidase II (MetAP2) activated in situ self-assembly of small-molecule probes for imaging prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B068  0.01
2018 Totten SM, Tanimoto C, Bermudez A, Hembree A, Brooks JD, Pitteri SJ. Abstract 5662: N-linked glycosylation site mapping in prostate cancer and matched normal tissue: Defining glycan microheterogeneity Cancer Research. 78: 5662-5662. DOI: 10.1158/1538-7445.Am2018-5662  0.01
2018 Helgstrand J, Røder M, Klemann N, Toft B, Lichtensztajn D, Brooks J, Brasso K, Vainer B, Iversen P. Incidence and survival trends of de-novo metastatic prostate cancer - a population-based analysis of two national cohorts from USA and Denmark European Urology Supplements. 17: e383-e384. DOI: 10.1016/S1569-9056(18)31119-9  0.01
2018 Sun A, Thomas I, Ganesan C, Sylman J, Pao A, Wagner T, Brooks J, Chertow G, Leppert J. MP28-15 PREOPERATIVE KIDNEY FUNCTION TRENDS: IMPROVING ESTIMATES OF BASELINE KIDNEY FUNCTION PRIOR TO KIDNEY CANCER SURGERY Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.915  0.01
2018 Sun A, Thomas I, Ganesan C, Sylman J, Pao A, Wagner T, Brooks J, Chertow G, Leppert J. MP28-07 RENAL FUNCTION VARIABILITY: A SIMPLE METHOD TO IDENTIFY SUBCLINICAL KIDNEY DISEASE BEFORE NEPHRECTOMY Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.907  0.01
2018 Magnani CJ, Li K, Seto T, McDonald KM, Blayney DW, Brooks JD, Hernandez-Boussard T. MP40-03 CHANGES IN PROSTATE SPECIFIC ANTIGEN SCREENING AND PROSTATE CANCER DIAGNOSIS AFTER GUIDELINE CHANGES Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.1270  0.01
2018 Cooperberg M, Faino A, Newcomb L, Carroll P, Kearns J, Brooks J, Fabrizio M, Gleave M, Morgan T, Dash A, Nelson P, Thompson I, Wagner A, Zheng Y, Lin D. PD20-01 WHEN CAN ACTIVE SURVEILLANCE (AS) BE LESS ACTIVE? PREDICTION OF LONG-TERM NON-RECLASSIFICATION FOR MEN WITH LOW-RISK PROSTATE CANCER Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1005  0.01
2017 Sonn GA, Fan RE, Ghanouni P, Wang NN, Brooks JD, Loening AM, Daniel BL, To'o KJ, Thong AE, Leppert JT. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists. European Urology Focus. PMID 29226826 DOI: 10.1016/J.Euf.2017.11.010  0.01
2017 Jeon HG, Yoo JH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM, Ferrari M, Brooks JD, Chung BI. Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance. Plos One. 12: e0186026. PMID 29136019 DOI: 10.1371/journal.pone.0186026  0.01
2017 Leppert JT, Lamberts RW, Thomas IC, Chung BI, Sonn GA, Skinner EC, Wagner TH, Chertow GM, Brooks JD. Incident CKD after Radical or Partial Nephrectomy. Journal of the American Society of Nephrology : Jasn. PMID 29018140 DOI: 10.1681/ASN.2017020136  0.01
2017 Loft MD, Berg KD, Kjaer A, Iversen P, Ferrari M, Zhang CA, Brasso K, Brooks JD, Røder MA. Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States. Clinical Genitourinary Cancer. PMID 28988695 DOI: 10.1016/j.clgc.2017.08.014  0.01
2017 Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer. Oncotarget. 8: 18657-18669. PMID 28423633 DOI: 10.18632/Oncotarget.15703  0.01
2017 Kirby MK, Ramaker RC, Roberts BS, Lasseigne BN, Gunther DS, Burwell TC, Davis NS, Gulzar ZG, Absher DM, Cooper SJ, Brooks JD, Myers RM. Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. Bmc Cancer. 17: 273. PMID 28412973 DOI: 10.1186/S12885-017-3252-2  0.01
2017 Gordon CA, Gong X, Ganesh D, Brooks JD. NUSAP1 promotes invasion and metastasis of prostate cancer. Oncotarget. PMID 28404898 DOI: 10.18632/Oncotarget.15604  0.01
2017 Banerjee S, Zare RN, Tibshirani RJ, Kunder CA, Nolley R, Fan R, Brooks JD, Sonn GA. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids. Proceedings of the National Academy of Sciences of the United States of America. PMID 28292895 DOI: 10.1073/Pnas.1700677114  0.01
2017 Hernandez-Boussard T, Kourdis P, Dulal R, Ferrari M, Henry S, Seto T, McDonald K, Blayney DW, Brooks JD. A natural language processing algorithm to measure quality prostate cancer care. Journal of Clinical Oncology. 35: 232-232. DOI: 10.1200/JCO.2017.35.8_SUPPL.232  0.01
2017 Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll P, Dash A, Ellis WJ, Fabrizio M, Gleave M, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. The use of five-alpha reductase inhibitors and their association with reclassification and pathologic outcomes in the Canary Prostate Active Surveillance Study (PASS). Journal of Clinical Oncology. 35: 22-22. DOI: 10.1200/Jco.2017.35.6_Suppl.22  0.01
2017 Thomas Helgstrand J, Klemann N, Toft BG, Vainer B, Brasso K, Brooks JD, Iversen P, Røder MA. Survival trends in patients diagnosed with metastatic prostate cancer: A nationwide analysis. Journal of Clinical Oncology. 35: 171-171. DOI: 10.1200/JCO.2017.35.6_SUPPL.171  0.01
2017 Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Abstract 4721: Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer Cancer Research. 77: 4721-4721. DOI: 10.1158/1538-7445.Am2017-4721  0.01
2017 Totten SM, Tanimoto C, Bermudez A, Hembree A, Brooks JD, Pitteri SJ. Abstract 2213: Aberrant glycoprotein expression in recurrent and non-recurrent prostate cancer tissue Cancer Research. 77: 2213-2213. DOI: 10.1158/1538-7445.Am2017-2213  0.01
2017 Røder M, Berg K, Loft M, Gerds T, Ferrari M, Thomsen F, Gruschy L, Kurbegovic S, Rytgaard H, Kjær A, Brasso K, Iversen P, Brooks J. The CPC risk calculator app: A validated tool to predict recurrence after radical prostatectomy. European Urology Supplements. 16: e1874-e1878. DOI: 10.1016/S1569-9056(17)31125-9  0.01
2017 Eminaga O, Shufeng L, Brooks J, Eisenberg M. Male infertility is associated with altered treatment course of men with cancer European Urology Supplements. 16: e1019. DOI: 10.1016/S1569-9056(17)30643-7  0.01
2017 Helgstrand J, Klemann N, Toft B, Vainer B, Brasso K, Brooks J, Iversen P, Røder M. Improved survival in patients diagnosed with metastatic prostate cancer – a nationwide analysis European Urology Supplements. 16: e76-e77. DOI: 10.1016/S1569-9056(17)30115-X  0.01
2017 Kearns J, Faino A, Newcomb L, Brooks J, Carroll P, Dash A, Ellis W, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Wagner A, Zheng Y, Lin D. PD55-02 THE USE OF FIVE-ALPHA REDUCTASE INHIBITORS AND THEIR ASSOCIATION WITH RECLASSIFICATION AND PATHOLOGIC OUTCOMES IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2425  0.01
2017 Guo D, Thomas I, Mittakanti H, Shelton J, Makarov D, Skolarus T, Cooperberg M, Sonn G, Chung B, Brooks J, Leppert J. PD47-10 THE RESEARCH IMPLICATIONS OF PSA REGISTRY ERRORS Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.2370  0.01
2017 Cooperberg M, Brooks J, Faino A, Zheng Y, Kearns J, Carroll P, Dash A, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Wagner A, Newcomb L, Lin D. MP43-11 REFINED ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA) VELOCITY TO PREDICT OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1321  0.01
2017 Kearns J, Faino A, Newcomb L, Brooks J, Carroll P, Dash A, Ellis W, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Wagner A, Zheng Y, Lin D. MP43-10 THE ROLE OF SURVEILLANCE BIOPSY WITH NO CANCER AS A PROGNOSTIC MARKER FOR RECLASSIFICATION: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1320  0.01
2017 Massoudi R, Hoerner C, Metzner T, O'Rourke J, Curtis R, Stell L, Sabatti C, Brooks J, Fan A, Leppert J. Mp39-10 Intra-Tumor Heterogeneity In Renal Cell Carcinoma: Implications For Proteomic Analysis Of Renal Mass Biopsies The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1184  0.01
2016 Røder MA, Berg KD, Loft MD, Thomsen FB, Ferrari M, Kurbegovic S, Rytgaard HC, Gruschy L, Brasso K, Gerds TA, Kjær A, Brooks JD, Iversen P. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy. European Urology Focus. PMID 28753827 DOI: 10.1016/j.euf.2016.11.014  0.01
2016 Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, et al. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. European Urology. PMID 27889277 DOI: 10.1016/J.Eururo.2016.11.017  0.01
2016 Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, ... ... Brooks JD, et al. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. Plos One. 11: e0165236. PMID 27846218 DOI: 10.1371/Journal.Pone.0165236  0.01
2016 Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. The Journal of Urology. PMID 27810448 DOI: 10.1016/J.Juro.2016.10.090  0.01
2016 McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, ... ... Brooks JD, et al. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. The American Journal of Surgical Pathology. PMID 27635949 DOI: 10.1097/Pas.0000000000000736  0.01
2016 Leppert JT, Mittakanti HR, Thomas IC, Lamberts RW, Sonn GA, Chung BI, Skinner EC, Wagner TH, Chertow GM, Brooks JD. Contemporary Use of Partial Nephrectomy: are Older Patients with Impaired Kidney Function Being Left behind? Urology. PMID 27634733 DOI: 10.1016/j.urology.2016.08.044  0.01
2016 Brooks JA, Shablack H, Gendron M, Satpute AB, Parrish MH, Lindquist KA. The Role of Language in the Experience and Perception of Emotion: A Neuroimaging Meta-Analysis. Social Cognitive and Affective Neuroscience. PMID 27539864 DOI: 10.1093/Scan/Nsw121  0.01
2016 Ahn B, Soundarapandian MM, Sessions H, Peddibhotla S, Roth GP, Li JL, Sugarman E, Koo A, Malany S, Wang M, Yea K, Brooks J, Leone TC, Han X, Vega RB, et al. MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling. The Journal of Clinical Investigation. PMID 27500491 DOI: 10.1172/JCI87382  0.01
2016 Brooks JC, Ford KI, Holder DH, Holtan MD, Easley CJ. Macro-to-micro interfacing to microfluidic channels using 3D-printed templates: application to time-resolved secretion sampling of endocrine tissue. The Analyst. PMID 27486597 DOI: 10.1039/C6An01055E  0.01
2016 Salehi S, Howe K, Brooks J, Lawrence ML, Bailey RH, Karsi A. Identification of Salmonella enterica serovar Kentucky genes involved in attachment to chicken skin. Bmc Microbiology. 16: 168. PMID 27473153 DOI: 10.1186/S12866-016-0781-9  0.01
2016 Schiller JR, Brooks JJ, Mansuripur PK, Gil JA, Akelman E. Three-Dimensional Carpal Kinematics after Carpal Tunnel Release. Journal of Wrist Surgery. 5: 222-6. PMID 27468373 DOI: 10.1055/s-0036-1578812  0.01
2016 Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM, Conrad C, Gentry J, Khudyakov Y, Waterhouse D, Owen SM, ... ... Brooks JT, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. The New England Journal of Medicine. 375: 229-239. PMID 27468059 DOI: 10.1056/NEJMoa1515195  0.01
2016 Brooks JT, Friedman A, Kachur RE, LaFlam M, Peters PJ, Jamieson DJ. Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus - United States, July 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 745-7. PMID 27466758 DOI: 10.15585/mmwr.mm6529e2  0.01
2016 Lee MH, Liprino L, Brooks J, Cayzer B, Weedon F, Bermingham K, Jenkins AJ, Rowley K, O'Neal DN. Factors associated with duration of inpatient hospital stay for patients with diabetes mellitus admitted to a medical unit in a community public hospital. Australian Journal of Primary Health. PMID 27465014 DOI: 10.1071/PY16036  0.01
2016 Mittakanti HR, Thomas IC, Chung BI, Sonn GA, Brooks JD, Leppert JT, Shelton JB, Cooperberg MR, Makarov DV, Skolarus TA. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27458297 DOI: 10.1200/JCO.2016.68.9216  0.01
2016 Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, et al. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer and Prostatic Diseases. PMID 27431498 DOI: 10.1038/Pcan.2016.28  0.01
2016 Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, Brooks JM. Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study. Bmc Health Services Research. 16: 274. PMID 27430623 DOI: 10.1186/s12913-016-1549-5  0.01
2016 Sinha SS, Cameron J, Brooks JC, Leifer CA. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events. Journal of Immunology (Baltimore, Md. : 1950). PMID 27421483 DOI: 10.4049/jimmunol.1502357  0.01
2016 Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods M, Concannon PJ, Bernstein JL. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. Breast Cancer Research : Bcr. 18: 65. PMID 27400983 DOI: 10.1186/S13058-016-0726-0  0.01
2016 Fogel SC, McElroy JA, Garbers S, McDonnell C, Brooks J, Eliason MJ, Ingraham N, Osborn A, Rayyes N, Redman SD, Wood SF, Haynes SG. Program Design for Healthy Weight in Lesbian and Bisexual Women: A Ten-City Prevention Initiative. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 26: S7-S17. PMID 27397919 DOI: 10.1016/J.Whi.2015.10.005  0.01
2016 Wood SF, Brooks J, Eliason MJ, Garbers S, McElroy JA, Ingraham N, Haynes SG. Recruitment and Participation of Older Lesbian and Bisexual Women in Intervention Research. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 26: S43-52. PMID 27397916 DOI: 10.1016/J.Whi.2016.04.003  0.01
2016 Ingraham N, Magrini D, Brooks J, Harbatkin D, Radix A, Haynes SG. Two Tailored Provider Curricula Promoting Healthy Weight in Lesbian and Bisexual Women. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 26: S36-42. PMID 27397914 DOI: 10.1016/j.whi.2016.04.001  0.01
2016 Brooks JK, Kleinman JW, Brooks JB, Reynolds MA. Electronic cigarette explosion associated with extensive intraoral injuries. Dental Traumatology : Official Publication of International Association For Dental Traumatology. PMID 27397137 DOI: 10.1111/edt.12293  0.01
2016 Kahler CW, Liu T, Cioe PA, Bryant V, Pinkston MM, Kojic EM, Onen N, Baker JV, Hammer J, Brooks JT, Patel P. Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART. Aids and Behavior. PMID 27392417 DOI: 10.1007/S10461-016-1474-Y  0.01
2016 Brooks JC, Pinto M, Gill A, Hills KE, Murthy S, Podgornik MN, Hernandez LF, Rose DA, Angulo FJ, Rzeszotarski P. Incident Management Systems and Building Emergency Management Capacity during the 2014-2016 Ebola Epidemic - Liberia, Sierra Leone, and Guinea. Mmwr Supplements. 65: 28-34. PMID 27389463 DOI: 10.15585/mmwr.su6503a5  0.01
2016 Breakwell L, Gerber AR, Greiner AL, Hastings DL, Mirkovic K, Paczkowski MM, Sidibe S, Banaski J, Walker CL, Brooks JC, Caceres VM, Arthur RR, Angulo FJ. Early Identification and Prevention of the Spread of Ebola in High-Risk African Countries. Mmwr Supplements. 65: 21-7. PMID 27389301 DOI: 10.15585/mmwr.su6503a4  0.01
2016 Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Barreira AA, Brooks JB, Claudino R, Correa EC, Ferreira ML, Finkelsztejn A, Finkelsztejn J, da Gama PD, Goncalves MV, Guerreiro CT, da Cunha Matta AP, et al. Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders. Neurorehabilitation. PMID 27372365 DOI: 10.3233/NRE-161361  0.01
2016 Hernandez-Boussard T, Tamang S, Blayney D, Brooks J, Shah N. New Paradigms for Patient-Centered Outcomes Research in Electronic Medical Records: An Example of Detecting Urinary Incontinence Following Prostatectomy. Egems (Washington, Dc). 4: 1231. PMID 27347492 DOI: 10.13063/2327-9214.1231  0.01
2016 Palella FJ, Armon C, Chmiel JS, Brooks JT, Hart R, Lichtenstein K, Novak RM, Yangco B, Wood K, Durham M, Buchacz K. CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk. The Journal of Antimicrobial Chemotherapy. PMID 27330061 DOI: 10.1093/jac/dkw196  0.01
2016 Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, et al. Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort. The Prostate. PMID 27325561 DOI: 10.1002/Pros.23225  0.01
2016 Hoyle CK, Tabberer M, Brooks J. Mapping the COPD Assessment Test onto EQ-5D. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 19: 469-77. PMID 27325339 DOI: 10.1016/j.jval.2016.01.005  0.01
2016 Srivastava AK, Wang Y, Huang R, Skinner C, Thompson T, Pollard L, Wood T, Luo F, Stevenson R, Polimanti R, Gelernter J, Lin X, Lim IY, Wu Y, Teh AL, ... ... Brooks JD, et al. Human genome meeting 2016: Houston, TX, USA. 28 February - 2 March 2016 Human Genomics. 10: 12-12. PMID 27294413 DOI: 10.1186/S40246-016-0063-5  0.01
2016 Gomez SL, Martínez ME, Brooks JD, Cheng I, Lichtensztajn D, Murphy JD. Reply to being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point. Cancer. PMID 27286520 DOI: 10.1002/Cncr.30097  0.01
2016 Knobel-Graves SM, Brooks JC, Johnson BJ, Starkey JD, Beckett JL, Hodgen JM, Hutcheson JP, Streeter MN, Thomas CL, Rathmann RJ, Garmyn AJ, Miller MF. Effect of vitamin D, zilpaterol hydrochloride supplementation, and postmortem aging on shear force measurements of three muscles in finishing beef steers. Journal of Animal Science. 94: 2637-2647. PMID 27285939 DOI: 10.2527/jas.2015-0121  0.01
2016 Brooks JP. Challenges for case-control studies with microbiome data. Annals of Epidemiology. 26: 336-341.e1. PMID 27255739 DOI: 10.1016/j.annepidem.2016.03.009  0.01
2016 Reid MJ, Switzer WM, Schillaci MA, Ragonnet M, Joanisse I, Caminiti K, Lowenberger CA, Galdikas BM, Sandstrom PA, Brooks JI. Detailed phylogenetic analysis of primate T-lymphotropic virus type 1 (PTLV-1) sequences from orangutans (Pongo pygmaeus) reveals new insights into the evolutionary history of PTLV-1 in Asia. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 27245152 DOI: 10.1016/j.meegid.2016.05.036  0.01
2016 Parr LA, Murphy L, Feczko E, Brooks J, Collantes M, Heitz TR. Experience-dependent changes in the development of face preferences in infant rhesus monkeys. Developmental Psychobiology. PMID 27242285 DOI: 10.1002/Dev.21434  0.01
2016 Gürlevik E, Fleischmann-Mundt B, Brooks J, Demir IE, Steiger K, Ribback S, Yevsa T, Woller N, Kloos A, Ostroumov D, Armbrecht N, Manns MP, Dombrowski F, Saborowski M, Kleine M, et al. Administration of Gemcitabine after Pancreatic Tumor Resection in Mice Induces an Anti-tumor Immune Response Mediated by Natural Killer Cells. Gastroenterology. PMID 27210037 DOI: 10.1053/j.gastro.2016.05.004  0.01
2016 Brooks JM, O'Donnell P, Frost DO. Olanzapine Treatment of Adolescent Rats Alters Adult D2 Modulation of Cortical Inputs to the Ventral Striatum. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207908 DOI: 10.1093/ijnp/pyw034  0.01
2016 Muschinski J, Feczko E, Brooks JM, Collantes M, Heitz TR, Parr LA. The development of visual preferences for direct versus averted gaze faces in infant macaques (Macaca mulatta). Developmental Psychobiology. PMID 27195755 DOI: 10.1002/Dev.21421  0.01
2016 Lauria MJ, Rush S, Weingart SD, Brooks J, Gallo IA. Potential role for psychological skills training in emergency medicine: Part 1 - Introduction and background. Emergency Medicine Australasia : Ema. PMID 27186788 DOI: 10.1111/1742-6723.12606  0.01
2016 Goedken AM, Lund BC, Cook EA, Schroeder MC, Brooks JM. Application of a framework for determining number of drugs. Bmc Research Notes. 9: 272. PMID 27178197 DOI: 10.1186/S13104-016-2076-5  0.01
2016 Obasi EM, Cavanagh L, Pittman DM, Brooks JJ. Effects of Evaluative Context in Implicit Cognitions Associated with Alcohol and Violent Behaviors. Addictive Behaviors Reports. 3: 48-55. PMID 27175442 DOI: 10.1016/J.Abrep.2016.04.003  0.01
2016 Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, ... ... Brooks JD, et al. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27174589 DOI: 10.1038/Modpathol.2016.88  0.01
2016 Hebden JN, Leaptrot D, Anttila A, Allen-Bridson K, Brooks JE, Gross C, Scalise E, Wright MO. Health care-associated infections studies project: An American Journal of Infection Control and National Healthcare Safety Network data quality collaboration 2016 Case #1. American Journal of Infection Control. PMID 27174462 DOI: 10.1016/j.ajic.2016.02.031  0.01
2016 Patel P, Bush T, Kojic EM, Overton ET, Henry K, Onen N, Rhame F, Conley L, Brooks J, Fry A. Duration of Influenza Virus Shedding among HIV-Infected Adults in the cART era, 2010-2011. Aids Research and Human Retroviruses. PMID 27174191 DOI: 10.1089/Aid.2015.0349  0.01
2016 Rhea S, Moorman A, Pace R, Mobley V, MacFarquhar J, Robinson E, Hayden T, Thai H, Drobeniuc J, Brooks JT, Moore Z, Patel PR. Hepatitis B Reverse Seroconversion and Transmission in a Hemodialysis Center: A Public Health Investigation and Case Report. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27161589 DOI: 10.1053/j.ajkd.2016.03.424  0.01
2016 Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, ... ... Brooks JD, et al. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer and Prostatic Diseases. PMID 27136741 DOI: 10.1038/Pcan.2016.12  0.01
2016 Brooks JP, McLaughlin MR, Adeli A, Miles DM. Cultivation and qPCR Detection of Pathogenic and Antibiotic-Resistant Bacterial Establishment in Naive Broiler Houses. Journal of Environmental Quality. 45: 958-66. PMID 27136163 DOI: 10.2134/Jeq2015.09.0492  0.01
2016 Brooks JA. Understanding Hospital Value-Based Purchasing. The American Journal of Nursing. 116: 63-6. PMID 27123637 DOI: 10.1097/01.NAJ.0000482974.56328.5a  0.01
2016 Condreay L, Huang L, Harris E, Brooks J, Riley JH, Church A, Ghosh S. Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary disease. Respiratory Medicine. 114: 123-6. PMID 27109822 DOI: 10.1016/j.rmed.2016.03.019  0.01
2016 Murugesan V, Lischuk A, Haims A, Lackman R, Brooks JS, Mankin H, Mistry PK. Vascular skeletal tumors in Gaucher disease: Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population. American Journal of Hematology. PMID 27102845 DOI: 10.1002/ajh.24398  0.01
2016 Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, Lee CH, Morris EA, Comstock CE. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results. Radiology. 151419. PMID 27097237 DOI: 10.1148/Radiol.2016151419  0.01
2016 Brooks JM, Long HM, Tierney RJ, Shannon-Lowe C, Leese AM, Fitzpatrick M, Taylor GS, Rickinson AB. Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination. Plos Pathogens. 12: e1005549. PMID 27096949 DOI: 10.1371/journal.ppat.1005549  0.01
2016 Brooks J, Murphy MT. A novel case of a broken dental anesthetic needle transecting the right internal carotid artery. Journal of the American Dental Association (1939). PMID 27087052 DOI: 10.1016/j.adaj.2016.03.014  0.01
2016 Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M, Kwit N, Mead P. Male-to-Male Sexual Transmission of Zika Virus - Texas, January 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 372-4. PMID 27078057 DOI: 10.15585/mmwr.mm6514a3  0.01
2016 Brooks JL, Guttridge TL, Franks BR, Grubbs RD, Chapman DD, Gruber SH, Dibattista JD, Feldheim KA. Using genetic inference to re-evaluate the minimum longevity of the lemon shark Negaprion brevirostris. Journal of Fish Biology. PMID 27060882 DOI: 10.1111/Jfb.12943  0.01
2016 Brooks J, Kellett J, Seeanner J, Jenkins C, Buchanan C, Kinsman A, Kelly D, Pierce S. Training the Motor Aspects of Pre-driving Skills of Young Adults With and Without Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 27055416 DOI: 10.1007/S10803-016-2775-8  0.01
2016 Schroeder MC, Tien YY, Wright K, Halfdanarson TR, Abu-Hejleh T, Brooks JM. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 95: 28-34. PMID 27040848 DOI: 10.1016/j.lungcan.2016.02.010  0.01
2016 Oster AM, Russell K, Stryker JE, Friedman A, Kachur RE, Petersen EE, Jamieson DJ, Cohn AC, Brooks JT. Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus - United States, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 323-5. PMID 27032078 DOI: 10.15585/Mmwr.Mm6512E3  0.01
2016 Petersen EE, Polen KN, Meaney-Delman D, Ellington SR, Oduyebo T, Cohn A, Oster AM, Russell K, Kawwass JF, Karwowski MP, Powers AM, Bertolli J, Brooks JT, Kissin D, Villanueva J, et al. Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 315-22. PMID 27031943 DOI: 10.15585/mmwr.mm6512e2  0.01
2016 Buyantseva LV, Brooks J, Rossi M, Lehman E, Craig TJ. Risk factors associated with 30-day asthma readmissions. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 53: 684-90. PMID 27031680 DOI: 10.3109/02770903.2016.1140773  0.01
2016 Newby KV, Parsons J, Brooks J, Leslie R, Inglis N. Identifying strategies to increase influenza vaccination in GP practices: a positive deviance approach. Family Practice. PMID 27025880 DOI: 10.1093/fampra/cmw016  0.01
2016 Kikugawa N, Goswami P, Kiswandhi A, Choi ES, Graf D, Baumbach RE, Brooks JS, Sugii K, Iida Y, Nishio M, Uji S, Terashima T, Rourke PM, Hussey NE, Takatsu H, et al. Interplanar coupling-dependent magnetoresistivity in high-purity layered metals. Nature Communications. 7: 10903. PMID 27020134 DOI: 10.1038/Ncomms10903  0.01
2016 Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity. British Journal of Pharmacology. 173: 1778-92. PMID 26990079 DOI: 10.1111/Bph.13476  0.01
2016 Brooks JF, Mandel MJ. The histidine kinase BinK is a negative regulator of biofilm formation and squid colonization. Journal of Bacteriology. PMID 26977108 DOI: 10.1128/Jb.00037-16  0.01
2016 Fitzpatrick M, Brooks JT, Kaplan JE. Epidemiology of HIV-Associated Lung Disease in the United States. Seminars in Respiratory and Critical Care Medicine. 37: 181-98. PMID 26974297 DOI: 10.1055/s-0036-1572556  0.01
2016 Alderman N, Major G, Brooks J. What can structured professional judgement tools contribute to management of neurobehavioural disability? Predictive validity of the Short-Term Assessment of Risk and Treatability (START) in acquired brain injury. Neuropsychological Rehabilitation. 1-18. PMID 26967151 DOI: 10.1080/09602011.2016.1158115  0.01
2016 Kwan CK, Rose CE, Brooks JT, Marks G, Sionean C. HIV Testing Among Men at Risk for Acquiring HIV Infection Before and After the 2006 CDC Recommendations. Public Health Reports (Washington, D.C. : 1974). 131: 311-9. PMID 26957666  0.01
2016 Barbosa PV, Thomas IC, Srinivas S, Buyyounouski MK, Chung BI, Chertow GM, Asch SM, Wagner TH, Brooks JD, Leppert JT. Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable? European Urology. PMID 26948397 DOI: 10.1016/j.eururo.2016.02.037  0.01
2016 Dryden M, Dickinson A, Brooks J, Hudgell L, Saeed K, Cutting KF. A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds. Journal of Wound Care. 25: 140, 142-6. PMID 26947694 DOI: 10.12968/jowc.2016.25.3.140  0.01
2016 Brooks JW. Postmortem Changes in Animal Carcasses and Estimation of the Postmortem Interval. Veterinary Pathology. 53: 929-40. PMID 26945004 DOI: 10.1177/0300985816629720  0.01
2016 Chrischilles EA, Schneider KM, Schroeder MC, Letuchy E, Wallace RB, Robinson JG, Brooks JM. Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction. Journal of the American Geriatrics Society. PMID 26928940 DOI: 10.1111/Jgs.13953  0.01
2016 Pokharel S, Brooks JC, Martin JN, Echeverry A, Parks AR, Corliss B, Brashears MM. Internalization and thermal susceptibility of Shiga toxin-producing Escherichia coli (STEC) in marinated beef products. Meat Science. 116: 213-220. PMID 26900979 DOI: 10.1016/J.Meatsci.2016.02.016  0.01
2016 Chapman CG, Brooks JM. Treatment Effect Estimation Using Nonlinear Two-Stage Instrumental Variable Estimators: Another Cautionary Note. Health Services Research. PMID 26891780 DOI: 10.1111/1475-6773.12463  0.01
2016 Hunt MR, Legako JF, Dinh TT, Garmyn AJ, O'Quinn TG, Corbin CH, Rathmann RJ, Brooks JC, Miller MF. Assessment of volatile compounds, neutral and polar lipid fatty acids of four beef muscles from USDA Choice and Select graded carcasses and their relationships with consumer palatability scores and intramuscular fat content. Meat Science. 116: 91-101. PMID 26874592 DOI: 10.1016/j.meatsci.2016.02.010  0.01
2016 Oster AM, Brooks JT, Stryker JE, Kachur RE, Mead P, Pesik NT, Petersen LR. Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 120-1. PMID 26866485 DOI: 10.15585/Mmwr.Mm6505E1  0.01
2016 Winkler AM, Webster MA, Brooks JC, Tracey I, Smith SM, Nichols TE. Non-parametric combination and related permutation tests for neuroimaging. Human Brain Mapping. PMID 26848101 DOI: 10.1002/Hbm.23115  0.01
2016 Buyantseva L, Brooks JP, Craig T. A 73-year-old woman with persistent diarrhea and onychomycosis. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 37: 76-9. PMID 26831851 DOI: 10.2500/aap.2016.37.3896  0.01
2016 Strother MC, Weissbart S, Brooks JS, Smith AL. Subpubic Cartilaginous Cyst - a Rare Periurethral Lesion with Implications for Surgical Approach. Urology. PMID 26826588 DOI: 10.1016/j.urology.2015.12.027  0.01
2016 Kalafatakis K, Russell GM, Harmer CJ, Munafo MR, Marchant N, Wilson A, Brooks JC, Thai NJ, Ferguson SG, Stevenson K, Durant C, Schmidt K, Lightman SL. Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial. Trials. 17: 44. PMID 26801980 DOI: 10.1186/s13063-016-1159-x  0.01
2016 Brooks JL, Darling S, Malvaso C, Della Sala S. Adult developmental trajectories of pseudoneglect in the tactile, visual and auditory modalities and the influence of starting position and stimulus length. Brain and Cognition. 103: 12-22. PMID 26799680 DOI: 10.1016/j.bandc.2015.12.001  0.01
2016 Abou Sawan S, Mazzulla M, Brooks J, Williamson E, Hirsh D. 'Engineering physiology' to understand the post-exercise biochemical milieu: mixing it up with anabolic hormones. The Journal of Physiology. 594: 263-4. PMID 26767888 DOI: 10.1113/JP271857  0.01
2016 Foerster CR, Brooks JR. Without acknowledging shortcomings, prehospital care in Ontario will not reach its full potential. Cjem. 18: 76. PMID 26717297 DOI: 10.1017/cem.2015.109  0.01
2016 Brooks JK, Schwartz KG, Basile JR. Superficial Mucocele of the Ventral Tongue: Presentation of a Rare Case and Literature Review. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 74: 1175-9. PMID 26706494 DOI: 10.1016/J.Joms.2015.11.025  0.01
2016 Ruone S, Paxton L, McLaurin T, Taylor A, Hanson D, Heneine W, Brooks JT, García-Lerma JG. Brief Report: HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate. Journal of Acquired Immune Deficiency Syndromes (1999). 72: 129-32. PMID 26689970 DOI: 10.1097/QAI.0000000000000921  0.01
2016 Honeychurch KC, Brooks J, Hart JP. Development of a voltammetric assay, using screen-printed electrodes, for clonazepam and its application to beverage and serum samples. Talanta. 147: 510-5. PMID 26592640 DOI: 10.1016/j.talanta.2015.10.032  0.01
2016 Lin D, Brown M, Newcomb L, Sjoberg D, Brooks J, Carroll P, Dash A, Fabrizio M, Gleave M, Morgan T, Nelson P, Thompson I, Zheng Y. PD08-02 EVALUATING THE FOUR KALLIKREIN PANEL OF THE 4KSCORE FOR PREDICTION OF HIGH-GRADE PROSTATE CANCER IN MEN IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2818  0.01
2016 Sonn G, Fan R, Li S, Ghanouni P, Loening A, Daniel B, To'o K, Gill H, Chung B, Brooks J. MP05-15 PROSTATE CANCER YIELD IN MRI LESIONS VARIES ACROSS RADIOLOGISTS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1992  0.01
2016 Davenport M, Li S, Brooks J, Cullen M, Eisenberg M. MP04-15 VASECTOMY AND THE RISK OF PROSTATE CANCER IN A PROSPECTIVE US COHORT: ANALYSIS IN THE PRESENCE OF SELECTION BIAS Journal of Urology. 195. DOI: 10.1016/j.juro.2016.02.1950  0.01
2016 Leppert J, Golla A, Thomas I, Lamberts R, Chung B, Sonn G, Srinivas S, Fan A, Wagner T, Master V, Brooks J, Chertow G, Patel C. MP03-17 SYSTEMATIC EVALUATION OF LABORATORY VALUES ASSOCIATED WITH SURVIVAL IN METASTATIC RENAL CELL CARCINOMA Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1910  0.01
2016 Mittakanti H, Thomas I, Lamberts R, Sonn G, Chung B, Wagner T, Chertow G, Brooks J, Leppert J. MP41-03 CHANGING UTILIZATION OF PARTIAL NEPHRECTOMY: ARE AT RISK PATIENTS BEING LEFT BEHIND? Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.170  0.01
2016 Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, ... ... Brooks JD, et al. PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer European Urology Focus. 2: 180-188. DOI: 10.1016/j.euf.2015.07.005  0.01
2015 Patel MR, Combs B, Hall P, Hough J, Chapman E, Perez A, Brooks JT, Peters PJ, Broz D. Reduction in Injection Risk Behaviors After Institution of an Emergency Syringe Exchange Program During an HIV Outbreak Among Persons Who Inject Drugs, Indiana 2015. Open Forum Infectious Diseases. 2: 638a. PMID 27437431 DOI: 10.1093/Ofid/Ofv130.10  0.01
2015 Buchacz K, Frazier EL, Hall HI, Hart R, Huang P, Franklin D, Hu X, Palella FJ, Chmiel JS, Novak RM, Wood K, Yangco B, Armon C, Brooks JT, Skarbinski J. A Matter of Perspective: Comparison of the Characteristics of Persons with HIV Infection in the United States from the HIV Outpatient Study, Medical Monitoring Project, and National HIV Surveillance System. The Open Aids Journal. 9: 123-33. PMID 26793282 DOI: 10.2174/1874613601509010123  0.01
2015 Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. Springerplus. 4: 825. PMID 26751177 DOI: 10.1186/S40064-015-1642-Y  0.01
2015 Liu S, Chang J, Long N, Beckwith K, Talhouarne G, Brooks JJ, Qu MH, Ren W, Wood JD, Cooper S, Bhargava A. Endogenous CRF in rat large intestine mediates motor and secretory responses to stress. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. PMID 26611915 DOI: 10.1111/Nmo.12725  0.01
2015 Nguyen EH, Taylor JL, Brooks J, Seizova-Cajic T. Velocity of motion across the skin influences perception of tactile location. Journal of Neurophysiology. jn.00707.2015. PMID 26609112 DOI: 10.1152/Jn.00707.2015  0.01
2015 Romei V, Bauer M, Brooks J, Economides M, Penny W, Thut G, Driver J, Bestmann S. Causal evidence that intrinsic beta-frequency is relevant for enhanced signal propagation in the motor system as shown through rhythmic TMS. Neuroimage. PMID 26584867 DOI: 10.1016/J.Neuroimage.2015.11.020  0.01
2015 Rebeiro PF, Althoff KN, Lau B, Gill J, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, et al. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. American Journal of Epidemiology. 182: 952-60. PMID 26578717 DOI: 10.1093/aje/kwv181  0.01
2015 O'Quinn TG, Woerner DR, Engle TE, Chapman PL, Legako JF, Brooks JC, Belk KE, Tatum JD. Identifying consumer preferences for specific beef flavor characteristics in relation to cattle production and postmortem processing parameters. Meat Science. 112: 90-102. PMID 26560806 DOI: 10.1016/J.Meatsci.2015.11.001  0.01
2015 Jamshidi N, Jonasch E, Zapala M, Korn RL, Brooks JD, Ljungberg B, Kuo MD. The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial. European Radiology. PMID 26560727 DOI: 10.1007/S00330-015-4082-8  0.01
2015 Legako JF, Dinh TT, Miller MF, Adhikari K, Brooks JC. Consumer palatability scores, sensory descriptive attributes, and volatile compounds of grilled beef steaks from three USDA Quality Grades. Meat Science. 112: 77-85. PMID 26555563 DOI: 10.1016/J.Meatsci.2015.10.018  0.01
2015 Williams S, Trewartha G, Kemp SP, Brooks JH, Fuller CW, Taylor AE, Cross MJ, Stokes KA. Time loss injuries compromise team success in Elite Rugby Union: a 7-year prospective study. British Journal of Sports Medicine. PMID 26552415 DOI: 10.1136/bjsports-2015-094798  0.01
2015 de La Vega MA, Caleo G, Audet J, Qiu X, Kozak RA, Brooks JI, Kern S, Wolz A, Sprecher A, Greig J, Lokuge K, Kargbo DK, Kargbo B, Di Caro A, Grolla A, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. The Journal of Clinical Investigation. PMID 26551677 DOI: 10.1172/JCI83162  0.01
2015 Conley LJ, Bush TJ, Rupert AW, Sereti I, Patel P, Brooks JT, Baker JV. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy. Aids (London, England). 29: 2201-7. PMID 26544583 DOI: 10.1097/Qad.0000000000000817  0.01
2015 Brooks J, Behrens E, Prickett K. Painful and Pruritic Papules in the Gray Shading of a Tattoo. Jama Dermatology. 1-2. PMID 26536150 DOI: 10.1001/jamadermatol.2015.3448  0.01
2015 Tabberer M, Brooks J, Wilcox T. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes. 13: 177. PMID 26520062 DOI: 10.1186/s12955-015-0369-3  0.01
2015 Brooks JM, Carrillo GL, Su J, Lindsay DS, Fox MA, Blader IJ. Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System. Mbio. 6. PMID 26507232 DOI: 10.1128/Mbio.01428-15  0.01
2015 Ortiz-Osorno AB, Ehler LA, Brooks J. Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 43: 619-32. PMID 26479571 DOI: 10.1111/jlme.12304  0.01
2015 Brooks JT, Ramji AF, Lyapustina TA, Yost MT, Ain MC. Low Prevalence of Anterior and Posterior Cruciate Ligament Injuries in Patients With Achondroplasia. Journal of Pediatric Orthopedics. PMID 26469688 DOI: 10.1097/BPO.0000000000000662  0.01
2015 Brooks J. Intragastric Balloon-Induced Ischemic Perforation. Obesity Surgery. PMID 26459433 DOI: 10.1007/s11695-015-1898-x  0.01
2015 Mian OY, Khattab MH, Hedayati M, Coulter J, Abubaker-Sharif B, Schwaninger JM, Veeraswamy RK, Brooks JD, Hopkins L, Shinohara DB, Cornblatt B, Nelson WG, Yegnasubramanian S, DeWeese TL. GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress. The Prostate. PMID 26447830 DOI: 10.1002/Pros.23111  0.01
2015 Jokerst JV, Chen Z, Xu L, Nolley R, Chang E, Mitchell B, Brooks JD, Gambhir SS. A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers. Plos One. 10: e0139484. PMID 26421725 DOI: 10.1371/Journal.Pone.0139484  0.01
2015 Jamshidi N, Jonasch E, Zapala M, Korn RL, Aganovic L, Zhao H, Tumkur Sitaram R, Tibshirani RJ, Banerjee S, Brooks JD, Ljungberg B, Kuo MD. The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma. Radiology. 277: 114-123. PMID 26402495 DOI: 10.1148/Radiol.2015150800  0.01
2015 Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, et al. Outcomes of active surveillance for the management of clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort. The Journal of Urology. PMID 26327354 DOI: 10.1016/J.Juro.2015.08.087  0.01
2015 Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, et al. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. Plos One. 10: e0132343. PMID 26172920 DOI: 10.1371/Journal.Pone.0132343  0.01
2015 Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, ... ... Brooks JD, et al. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. The Prostate. 75: 1206-15. PMID 25939393 DOI: 10.1002/Pros.23003  0.01
2015 Sieh W, Lichtensztajn DY, Gomez SL, Liu JJ, Chung BI, Cheng I, Brooks JD. Re: Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer: authors' reply. Pathology. 47: 394-5. PMID 25938367 DOI: 10.1097/Pat.0000000000000264  0.01
2015 Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. European Urology. 68: 1083-8. PMID 25819722 DOI: 10.1016/J.Eururo.2015.03.023  0.01
2015 Gordon CA, Gulzar ZG, Brooks JD. NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells. The Prostate. 75: 517-26. PMID 25585568 DOI: 10.1002/Pros.22938  0.01
2015 Eisenberg ML, Li S, Brooks JD, Cullen MR, Baker LC. Increased risk of cancer in infertile men: analysis of U.S. claims data. The Journal of Urology. 193: 1596-601. PMID 25463997 DOI: 10.1016/j.juro.2014.11.080  0.01
2015 Lee JJ, Thomas IC, Nolley R, Ferrari M, Brooks JD, Leppert JT. Biologic differences between peripheral and transition zone prostate cancer. The Prostate. 75: 183-90. PMID 25327466 DOI: 10.1002/pros.22903  0.01
2015 Chang SL, Kibel AS, Brooks JD, Chung BI. The impact of robotic surgery on the surgical management of prostate cancer in the USA. Bju International. 115: 929-36. PMID 24958338 DOI: 10.1111/bju.12850  0.01
2015 Gong X, Pollack J, Brooks JD. Abstract A1-70: Klip1 lincRNA is a prognostic biomarker for clear cell renal cell carcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-70  0.01
2015 Totten SM, Kulloli M, Tanimoto C, Brooks JD, Pitteri SJ. Abstract 1835: In-depth quantitative analysis of protein glycoforms in human prostate cancer plasma Cancer Research. 75: 1835-1835. DOI: 10.1158/1538-7445.Am2015-1835  0.01
2015 Lotan TL, Wei W, Morais CL, Feng Z, Hawley S, Fazli L, Hurtado-Coll A, Troyer D, McKenney J, Simko J, True L, Brooks JD, Biomarkers CPTIT. Mp6-13 Pten Loss By Immunohistochemistry Is Associated With Biochemical Recurrence In Erg-Negative Prostate Tumors: A Study Of The Canary Cohort The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.260  0.01
2015 Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Yang H, Lin DW. PD34-03 TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2239  0.01
2015 Lamberts R, Thomas I, Chung B, Sonn G, Fan A, Srinivas S, Wagner T, Chertow G, Brooks J, Leppert J. MP84-02 DIFFERING KIDNEY FUNCTION OUTCOMES FOLLOWING KIDNEY CANCER SURGERY IN THE VETERANS HEALTH ADMINISTRATION Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1969  0.01
2015 Lotan TL, Morais CL, Wei W, Jamaspishvili T, Feng Z, McKenney J, Simko J, Troyer D, True L, Brooks JD, Squire J, Biomarkers CPTIT. Mp1-17 Pten Status Determination In Prostate Cancer: Comparison Of Ihc And Fish In A Large Multi-Center Cohort The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.180  0.01
2014 Lasseigne BN, Burwell TC, Patil MA, Absher DM, Brooks JD, Myers RM. DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. Bmc Medicine. 12: 235. PMID 25472429 DOI: 10.1186/S12916-014-0235-X  0.01
2014 Yu YP, Ding Y, Chen Z, Liu S, Michalopoulos A, Chen R, Gulzar ZG, Yang B, Cieply KM, Luvison A, Ren BG, Brooks JD, Jarrard D, Nelson JB, Michalopoulos GK, et al. Novel fusion transcripts associate with progressive prostate cancer. The American Journal of Pathology. 184: 2840-9. PMID 25238935 DOI: 10.1016/J.Ajpath.2014.06.025  0.01
2014 Billingsley KL, Park JM, Josan S, Hurd R, Mayer D, Spielman-Sun E, Nishimura DG, Brooks JD, Spielman D. The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate. Magnetic Resonance Imaging. 32: 791-5. PMID 24907854 DOI: 10.1016/J.Mri.2014.04.015  0.01
2014 Chen Z, Gulzar ZG, St Hill CA, Walcheck B, Brooks JD. Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers. The Prostate. 74: 1059-67. PMID 24854630 DOI: 10.1002/Pros.22826  0.01
2014 Liu JJ, Lichtensztajn DY, Gomez SL, Sieh W, Chung BI, Cheng I, Brooks JD. Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer. Pathology. 46: 306-10. PMID 24798166 DOI: 10.1097/Pat.0000000000000097  0.01
2014 Leppert JT, Hanley J, Wagner TH, Chung BI, Brooks JD, Srinivas S, Chertow GM, Saigal CS. Reply: To PMID 24529583. Urology. 83: 779-80. PMID 24529590 DOI: 10.1016/j.urology.2013.10.077  0.01
2014 Leppert JT, Hanley J, Wagner TH, Chung BI, Srinivas S, Chertow GM, Brooks JD, Saigal CS. Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology. 83: 774-9. PMID 24529579 DOI: 10.1016/j.urology.2013.10.073  0.01
2014 Lichtensztajn DY, Gomez SL, Sieh W, Chung BI, Cheng I, Brooks JD. Prostate cancer risk profiles of Asian-American men: disentangling the effects of immigration status and race/ethnicity. The Journal of Urology. 191: 952-6. PMID 24513166 DOI: 10.1016/J.Juro.2013.10.075  0.01
2014 Conti SL, Thomas IC, Hagedorn JC, Chung BI, Chertow GM, Wagner TH, Brooks JD, Srinivas S, Leppert JT. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. International Journal of Cancer. Journal International Du Cancer. 134: 2245-52. PMID 24135850 DOI: 10.1002/ijc.28553  0.01
2014 Busch J, Magheli A, Leva N, Ferrari M, Kramer J, Klopf C, Kempkensteffen C, Miller K, Brooks JD, Gonzalgo ML. Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance. Bju International. 114: 517-21. PMID 24112652 DOI: 10.1111/bju.12466  0.01
2014 Hernandez-Boussard T, Tamang S, Brooks JD, Blayney DW, Shah N. Measurement of urinary incontinence after prostate surgery from data-mining electronic health records (EHR). Journal of Clinical Oncology. 32: 6612-6612. DOI: 10.1200/Jco.2014.32.15_Suppl.6612  0.01
2014 Harshman LC, Muller K, Lin C, Brooks JD, Higgins J, Berglin J, Hunter T, Copp J. Characterization of the mTOR autophosphorylation site, S2481, as a novel biomarker in renal cell carcinoma (RCC). Journal of Clinical Oncology. 32: 4571-4571. DOI: 10.1200/Jco.2014.32.15_Suppl.4571  0.01
2014 Barbosa P, Hammam O, Nolley R, Metzner T, Fan A, Srinivas S, Peehl D, Brooks J, Leppert J. MP29-06 IQGAP1 EXPRESSION AND SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.748  0.01
2014 Barbosa P, Thomas I, Chung B, Srinivas S, Wagner T, Brooks J, Leppert J. MP78-20 OVERALL SURVIVAL AMONG LOW-RISK PROSTATE CANCER PATIENTS TREATED IN THE VA HEALTH CARE SYSTEM Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2503  0.01
2013 Leppert J, Liliental JE, Xu L, Thong AE, Yost C, Yaghi A, Brooks JD, Harshman LC, Sabatti C, Srinivas S, Felsher DW. Nanoscale proteomic profiling to define diagnostic signatures and biomarkers of therapeutic activity in patients with RCC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 432. PMID 28136981 DOI: 10.1200/Jco.2013.31.6_Suppl.432  0.01
2013 Day K, Waite LL, Thalacker-Mercer A, West A, Bamman MM, Brooks JD, Myers RM, Absher D. Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape. Genome Biology. 14: R102. PMID 24034465 DOI: 10.1186/Gb-2013-14-9-R102  0.01
2013 Brooks JD. Managing localized prostate cancer in the era of prostate-specific antigen screening. Cancer. 119: 3906-9. PMID 24006273 DOI: 10.1002/cncr.28301  0.01
2013 Wallace TC, MacKay D, Ritz BW, McBurney M, Shao A, Miller J, Brooks J, Hendricks L. An industry perspective: dietary supplements and mortality rates in older women. Journal of Dietary Supplements. 10: 85-92. PMID 23679573 DOI: 10.3109/19390211.2013.783661  0.01
2013 Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2442-50. PMID 23515404 DOI: 10.1158/1078-0432.Ccr-12-3283  0.01
2013 Brooks JD. Epigenetic changes in histologically normal prostate tissues. The Journal of Urology. 189: 2020-1. PMID 23465550 DOI: 10.1016/j.juro.2013.02.3193  0.01
2013 Howitt BE, Brooks JD, Jones S, Higgins JP. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 21: 401-7. PMID 23343953 DOI: 10.1097/PAI.0b013e31827b505f  0.01
2013 Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, ... ... Brooks JD, et al. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Advances in Anatomic Pathology. 20: 39-44. PMID 23232570 DOI: 10.1097/Pap.0B013E31827B665B  0.01
2013 Wu B, Sahoo D, Brooks JD. Comprehensive gene expression changes associated with mouse postnatal kidney development. The Journal of Urology. 189: 2385-90. PMID 23220383 DOI: 10.1016/J.Juro.2012.12.002  0.01
2013 Sangoi AR, McKenney JK, Brooks JD, Higgins JP. Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 21: 318-21. PMID 23165333 DOI: 10.1097/PAI.0b013e318277cf5a  0.01
2013 Gulzar ZG, McKenney JK, Brooks JD. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene. 32: 70-7. PMID 22349817 DOI: 10.1038/onc.2012.27  0.01
2013 Cooperberg MR, Newcomb LF, Brown EC, Zhao S, Feng Z, Brooks JD, Lin DW, Investigators CP. The impact of reducing the frequency of prostate specific antigen (PSA) testing among men on active surveillance for prostate cancer. Journal of Clinical Oncology. 31: 5092-5092. DOI: 10.1200/Jco.2013.31.15_Suppl.5092  0.01
2013 Mei G, Sebisanovic D, Mir A, Gulzar Z, Brooks JD, Jeffrey SS, Talasaz A. Liquid biopsy-based assays to monitor residual disease in cancer. Journal of Clinical Oncology. 31: 11096-11096. DOI: 10.1200/jco.2013.31.15_suppl.11096  0.01
2013 Gordon CA, Gong X, Gulzar ZG, Brooks JD. Abstract B15: NuSAP is regulated by RB1 and modulates prostate cancer progression Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B15  0.01
2013 Fan AC, Leppert J, Liliental JE, Xu L, Metzner TJ, Shroff E, Yaghi A, Yost C, Brooks JD, Harshman LC, Sabatti C, Srinivas S, Felsher DW. Abstract 2283: Nano-scale proteomic profiles of response to targeted therapy in patients with RCC. Cancer Research. 73: 2283-2283. DOI: 10.1158/1538-7445.Am2013-2283  0.01
2013 Lee JJ, Patel CJ, Brooks JD, Leppert JT. 338 AN ENVIRONMENT-WIDE ASSOCIATION STUDY (EWAS) ON PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.1724  0.01
2013 Leppert J, Fan A, Liliental J, Xu L, Thong A, Yost C, Yaghi A, Metzner T, Brooks J, Harshman L, Sabatti C, Srinivas S, Felsher D. 603 NANO-SCALE PROTEOMIC PROFILING TO DEFINE DIAGNOSTIC SIGNATURES AND BIOMARKERS OF THERAPEUTIC ACTIVITY IN RCC Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.154  0.01
2012 Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll P, Feng Z, Gleave ME, Lance R, Sanda MG, Thompson IM, Wei J, Nelson P. Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2. PMID 27968277 DOI: 10.1200/Jco.2012.30.5_Suppl.2  0.01
2012 Liu JJ, Brooks JD, Ferrari M, Nolley R, Presti JC. Performance characteristics of PSA in patients undergoing radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 199. PMID 27968135 DOI: 10.1200/jco.2012.30.5_suppl.199  0.01
2012 Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. Plos One. 7: e49144. PMID 23145101 DOI: 10.1371/Journal.Pone.0049144  0.01
2012 Wu B, Brooks JD. Gene expression changes induced by unilateral ureteral obstruction in mice. The Journal of Urology. 188: 1033-41. PMID 22819101 DOI: 10.1016/j.juro.2012.05.004  0.01
2012 Liu JJ, Ferrari M, Nolley R, Brooks JD, Presti JC. Performance characteristics of prostate-specific antigen in patients undergoing radical prostatectomy. Urology. 79: 1336-9. PMID 22516358 DOI: 10.1016/j.urology.2012.02.036  0.01
2012 Sangoi AR, McKenney JK, Brooks JD, Bonventre JV, Higgins JP. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 20: 451-3. PMID 22495365 DOI: 10.1097/PAI.0b013e31824bb404  0.01
2012 Kimm SY, Tarin TV, Lee JH, Hu B, Jensen K, Nishimura D, Brooks JD. Methods for registration of magnetic resonance images of ex vivo prostate specimens with histology Journal of Magnetic Resonance Imaging. 36: 206-212. PMID 22359365 DOI: 10.1002/Jmri.23614  0.01
2012 Chernikova SB, Razorenova OV, Higgins JP, Sishc BJ, Nicolau M, Dorth JA, Chernikova DA, Kwok S, Brooks JD, Bailey SM, Game JC, Brown JM. Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Research. 72: 2111-9. PMID 22354749 DOI: 10.1158/0008-5472.CAN-11-2209  0.01
2012 Brooks JD. Translational genomics: the challenge of developing cancer biomarkers. Genome Research. 22: 183-7. PMID 22301132 DOI: 10.1101/gr.124347.111  0.01
2012 Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack JR. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene. 31: 4164-4170. PMID 22179824 DOI: 10.1038/Onc.2011.590  0.01
2012 King CR, Brooks JD, Gill H, Presti JC. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer International Journal of Radiation Oncology Biology Physics. 82: 877-882. PMID 21300474 DOI: 10.1016/j.ijrobp.2010.11.054  0.01
2012 Weinberg AE, Brooks JD. PIVOT and the challenges of localized prostate cancer care Translational Andrology and Urology. 1: 141-143. DOI: 10.3978/j.issn.2223-4683.2012.08.01  0.01
2012 Fan AC, Banerjee P, Leppert J, Harshman LC, Sabatti C, Brooks JD, Felsher DW. Use of nano-immuno assay to generate rapid, quantitative nanoscale proteomic profiling of the hypoxia pathway in renal cell carcinoma clinical specimens. Journal of Clinical Oncology. 30: 10513-10513. DOI: 10.1200/Jco.2012.30.15_Suppl.10513  0.01
2012 Sieh W, Lichtensztajn DY, Nelson DO, Cockburn M, West DW, Brooks JD, Chang ET. Abstract 5513: Treatment and mortality in men with localized prostate cancer: A population-based study in California Cancer Research. 72: 5513-5513. DOI: 10.1158/1538-7445.Am2012-5513  0.01
2012 Sangoi AR, McKenney JK, Brooks JD, Higgins JP. Evaluation of SF-1 Expression in Testicular Germ Cell Tumors: A Tissue Microarray Study of 100 Cases American Journal of Clinical Pathology. 138: A355-A355. DOI: 10.1093/ajcp/138.suppl1.331  0.01
2012 Truong M, Yang B, Kobayashi Y, Brooks J, Jarrard D. 1315 Even-Skipped Homeobox 1 (Evx1) Is Frequently Hypermethylated In Prostate Cancer And Predicts Psa Recurrence The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1662  0.01
2012 Lin D, Newcomb L, Ellis W, Gleave M, Thompson I, Brooks J, Nelson P, Sanda M, Lance R, Wei J, Feng Z, Carroll P. 990 Progression And Treatment In A Multi-Institutional, Prospective Active Surveillance Study: Results From Canary Prostate Active Surveillance Study (Pass) The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1091  0.01
2011 Ngo TC, Lee JJ, Brooks JD, Nolley R, Ferrari M, Presti JC. Smoking and adverse outcomes at radical prostatectomy. Urologic Oncology. 31: 749-54. PMID 21824793 DOI: 10.1016/j.urolonc.2011.06.013  0.01
2011 McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll PR, Brooks JD. The potential impact of reproducibility of gleason grading in men with early stage prostate cancer managed by active surveillance: A multi-institutional study Journal of Urology. 186: 465-469. PMID 21679996 DOI: 10.1016/j.juro.2011.03.115  0.01
2011 Malhotra S, Lapointe J, Salari K, Higgins JP, Ferrari M, Montgomery K, van de Rijn M, Brooks JD, Pollack JR. A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. Plos One. 6: e20293. PMID 21629784 DOI: 10.1371/Journal.Pone.0020293  0.01
2011 Kobayashi Y, Absher DM, Gulzar ZG, Young SR, McKenney JK, Peehl DM, Brooks JD, Myers RM, Sherlock G. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Research. 21: 1017-27. PMID 21521786 DOI: 10.1101/Gr.119487.110  0.01
2011 Liu JJ, Brooks JD, Ferrari M, Nolley R, Presti JC. Small prostate size and high grade disease--biology or artifact? The Journal of Urology. 185: 2108-11. PMID 21496855 DOI: 10.1016/j.juro.2011.02.053  0.01
2011 Hsu M, Chang SL, Ferrari M, Nolley R, Presti JC, Brooks JD. Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy. International Journal of Urology : Official Journal of the Japanese Urological Association. 18: 272-9. PMID 21342296 DOI: 10.1111/j.1442-2042.2011.02729.x  0.01
2011 Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 425-9. PMID 21102418 DOI: 10.1038/modpathol.2010.196  0.01
2011 Ngo T, Lee J, Brooks J, Nolley R, Ferrari M, Presti J. 459 SMOKING AND ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.552  0.01
2011 Gulzar Z, Brooks J. 1614 INCREASED EXPRESSION OF NUSAP GENE IN RECURRENT PROSTATE CANCER IS MEDIATED BY E2F Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.1722  0.01
2010 Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & Cancer. 1: 152-163. PMID 20871783 DOI: 10.1177/1947601909359929  0.01
2010 Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. Human Pathology. 41: 1145-9. PMID 20413145 DOI: 10.1016/j.humpath.2010.01.010  0.01
2010 Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 75: 407-13. PMID 19758683 DOI: 10.1016/J.Urology.2009.05.050  0.01
2010 Bhamre S, Sahoo D, Tibshirani R, Dill DL, Brooks JD. Gene Expression Changes Induced by Genistein in the Prostate Cancer Cell Line LNCaP The Open Prostate Cancer Journal. 3: 86-98. DOI: 10.2174/1876822901003010086  0.01
2010 Sieh W, Lichtensztajn DY, Nelson DO, Cockburn M, West DW, Brooks JD, Chang ET. Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California The Open Prostate Cancer Journal. 6: 1-8. DOI: 10.2174/1874079001306010001  0.01
2010 Brannon AR, Reddy A, Seiler M, Arreola A, Chen S, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Abstract 1996: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns Cancer Research. 70: 1996-1996. DOI: 10.1158/1538-7445.Am10-1996  0.01
2010 Talasaz AH, Cann G, Gulzar Z, Chen J, April C, Klotzle B, Tat M, Li R, Liu S, Schroth G, Brooks JD, Fan J, Ronaghi M. Abstract 1144: High-throughput genetic and expression analysis of circulating tumor cells Cancer Research. 70: 1144-1144. DOI: 10.1158/1538-7445.Am10-1144  0.01
2010 Kimm SY, Shinghal R, Liu JJ, Srinivas S, Brooks J, Presti J, Leppert JT. 835 PRIMARY TESTICULAR LYMPHOMA: ANALYSIS OF 155 CASES FROM THE VETERANS AFFAIRS CENTRAL CANCER REGISTRY Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.2337  0.01
2010 King C, Brooks J, Gill H, Presti J. Patient-Reported Long-term Outcomes after Hypofractionated Stereotactic Radiotherapy for Low-risk Prostate Cancer: Evidence from a Prospective Trial International Journal of Radiation Oncology*Biology*Physics. 78: S336. DOI: 10.1016/J.IJROBP.2010.07.796  0.01
2009 Williams AA, Higgins JP, Zhao H, Ljunberg B, Brooks JD. CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. Bmc Clinical Pathology. 9: 9. PMID 19922654 DOI: 10.1186/1472-6890-9-9  0.01
2009 Chung BI, Tarin TV, Ferrari M, Brooks JD. Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival. Urologic Oncology. 29: 314-8. PMID 19837617 DOI: 10.1016/j.urolonc.2009.06.017  0.01
2009 Holterhus PM, Bebermeier JH, Werner R, Demeter J, Richter-Unruh A, Cario G, Appari M, Siebert R, Riepe F, Brooks JD, Hiort O. Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. Bmc Genomics. 10: 292. PMID 19570224 DOI: 10.1186/1471-2164-10-292  0.01
2009 Zhao H, Zongming Ma, Tibshirani R, Higgins JP, Ljungberg B, Brooks JD. Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas. Plos One. 4: e6039. PMID 19557179 DOI: 10.1371/Journal.Pone.0006039  0.01
2009 Higgins JP, McKenney JK, Brooks JD, Argani P, Epstein JI. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. Human Pathology. 40: 456-63. PMID 19289184 DOI: 10.1016/j.humpath.2008.12.004  0.01
2009 Gardner CD, Oelrich B, Liu JP, Feldman D, Franke AA, Brooks JD. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation Prostate. 69: 719-726. PMID 19180569 DOI: 10.1002/pros.20922  0.01
2009 Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM, Feldman D. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. International Journal of Cancer. Journal International Du Cancer. 124: 2050-9. PMID 19127598 DOI: 10.1002/ijc.24161  0.01
2009 King CR, Ferrari M, Brooks JD. Prognostic significance of prostate cancer originating from the transition zone. Urologic Oncology. 27: 592-7. PMID 18799332 DOI: 10.1016/j.urolonc.2008.05.009  0.01
2009 King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. International Journal of Radiation Oncology, Biology, Physics. 73: 1043-8. PMID 18755555 DOI: 10.1016/j.ijrobp.2008.05.059  0.01
2009 Kimm S, Tarin TV, Lee JH, Nishimura DG, Jensen KC, Hu BS, Lee DS, Brooks JD. CORRELATION OF HISTOLOGIC SECTIONS AND MAGNETIC RESONANCE IMAGING IN EX-VIVO HUMAN PROSTATE SPECIMENS Journal of Urology. 181: 783-783. DOI: 10.1016/S0022-5347(09)62180-7  0.01
2009 Oelrich B, Liu J, Feldman D, Franke A, Brooks JD, Gardner C. PROSTATIC CONCENTRATION OF SOY ISOFLAVONE EXCEEDS SERUM AFTER DIETARY SUPPLEMENTATION Journal of Urology. 181: 47-48. DOI: 10.1016/S0022-5347(09)60146-4  0.01
2009 Brooks JD, Zhao H, Ma Z, Tibshirani R, Higgins JP, Ljungberg B. ALTERATION OF GENE EXPRESSION SIGNATURES OF CORTICAL DIFFERENTIATION AND WOUND RESPONSE IN LETHAL CONVENTIONAL RENAL CELL CARCINOMAS Journal of Urology. 181: 39-39. DOI: 10.1016/S0022-5347(09)60122-1  0.01
2008 Thompson M, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. The Prostate. 68: 1248-56. PMID 18500686 DOI: 10.1002/Pros.20792  0.01
2008 Lapointe J, Malhotra S, Higgins JP, Bair E, Thompson M, Salari K, Giacomini CP, Ferrari M, Montgomery K, Tibshirani R, van de Rijn M, Brooks JD, Pollack JR. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. The American Journal of Surgical Pathology. 32: 205-9. PMID 18223322 DOI: 10.1097/Pas.0B013E318124A865  0.01
2008 King CR, Presti JC, Brooks JD, Gill H, Spiotto MT. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy. International Journal of Radiation Oncology, Biology, Physics. 70: 1472-7. PMID 17935902 DOI: 10.1016/J.Ijrobp.2007.08.014  0.01
2008 Brooks JD, Tibshirani R, Ferrari M, Presti JC, Gill H, King CR. The Impact of Tumor Volume on Outcomes after Radical Prostatectomy: Implications for Prostate Cancer Screening The Open Prostate Cancer Journal. 1: 1-8. DOI: 10.2174/1876822900801010001  0.01
2008 Tarin TV, Chung BI, Brooks JD. DO CANCER INDEX AND TUMOR VOLUME PREDICT PROSTATE CANCER SPECIFIC DEATH? Journal of Urology. 179: 115-115. DOI: 10.1016/S0022-5347(08)60330-4  0.01
2008 Brooks J. Why most published research findings are false. Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece Urologic Oncology: Seminars and Original Investigations. 26: 571-572. DOI: 10.1016/j.urolonc.2008.07.015  0.01
2008 Brooks J. Multiple loci identified in a genome-wide association study of prostate cancer. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E Urologic Oncology: Seminars and Original Investigations. 26: 571. DOI: 10.1016/j.urolonc.2008.07.014  0.01
2008 Brooks J. Multiple newly identified loci associated with prostate cancer susceptibility. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM Urologic Oncology: Seminars and Original Investigations. 26: 570. DOI: 10.1016/j.urolonc.2008.07.013  0.01
2008 Brooks J. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP Urologic Oncology: Seminars and Original Investigations. 26: 569-570. DOI: 10.1016/j.urolonc.2008.07.012  0.01
2008 Brooks J. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB, Mehra R, Chinnaiyan AM, Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI Urologic Oncology: Seminars and Original Investigations. 26: 569. DOI: 10.1016/j.urolonc.2008.07.011  0.01
2008 Brooks J. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM, Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, TX Urologic Oncology: Seminars and Original Investigations. 26: 568-569. DOI: 10.1016/j.urolonc.2008.07.010  0.01
2007 Holterhus PM, Deppe U, Werner R, Richter-Unruh A, Bebermeier JH, Wünsch L, Krege S, Schweikert HU, Demeter J, Riepe F, Hiort O, Brooks JD. Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. Bmc Genomics. 8: 376. PMID 17945006 DOI: 10.1186/1471-2164-8-376  0.01
2007 Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, Ferrari M, Hernandez-Boussard T, Brooks JD, Pollack JR. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Research. 67: 8504-10. PMID 17875689 DOI: 10.1158/0008-5472.Can-07-0673  0.01
2007 Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC, van de Rijn M, Brooks JD. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. The American Journal of Surgical Pathology. 31: 673-80. PMID 17460449 DOI: 10.1097/01.pas.0000213438.01278.5f  0.01
2007 Li TH, Zhao H, Peng Y, Beliakoff J, Brooks JD, Sun Z. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Research. 35: 2767-76. PMID 17426117 DOI: 10.1093/Nar/Gkm198  0.01
2007 Lapointe J, Kim YH, Miller MA, Li C, Kaygusuz G, van de Rijn M, Huntsman DG, Brooks JD, Pollack JR. A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 467-73. PMID 17334351 DOI: 10.1038/Modpathol.3800759  0.01
2007 Zhao H, Brooks JD. Selenomethionine induced transcriptional programs in human prostate cancer cells. The Journal of Urology. 177: 743-50. PMID 17222674 DOI: 10.1016/J.Juro.2006.09.071  0.01
2007 Zhao H, Ramos CF, Brooks JD, Peehl DM. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. Journal of Cellular Physiology. 210: 111-21. PMID 17044071 DOI: 10.1002/Jcp.20828  0.01
2007 Pflug BR, Zheng H, Udan MS, D'Antonio JM, Marshall FF, Brooks JD, Nelson JB. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Letters. 246: 139-48. PMID 16581180 DOI: 10.1016/j.canlet.2006.02.007  0.01
2007 Colocci N, King CR, Brooks JD, Gill HS, Presti JC, Srinivas S. Adjuvant docetaxel chemotherapy with abbreviated hormonal therapy in patients with high-risk prostate cancer Journal of Clinical Oncology. 25: 15589-15589. DOI: 10.1200/JCO.2007.25.18_SUPPL.15589  0.01
2006 Li S, Bhamre S, Lapointe J, Pollack JR, Brooks JD. Application of genomic technologies to human prostate cancer. Omics : a Journal of Integrative Biology. 10: 261-75. PMID 17069507 DOI: 10.1089/Omi.2006.10.261  0.01
2006 Bebermeier JH, Brooks JD, DePrimo SE, Werner R, Deppe U, Demeter J, Hiort O, Holterhus PM. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. Journal of Molecular Medicine (Berlin, Germany). 84: 919-31. PMID 16932916 DOI: 10.1007/S00109-006-0081-1  0.01
2006 King CR, McNeal JE, Gill H, Brooks JD, Srinivas S, Presti JC. Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade. Urology. 67: 1229-34. PMID 16765184 DOI: 10.1016/J.UROLOGY.2005.12.031  0.01
2006 Ma JF, Coutre SE, Curet MJ, Brooks JD. Refractory hematuria from amyloidosis successfully treated by splenectomy. Urology. 67: 1085.e13-5. PMID 16698382 DOI: 10.1016/j.urology.2005.11.048  0.01
2006 Jones SB, Brooks JD. Modest induction of phase 2 enzyme activity in the F-344 rat prostate. Bmc Cancer. 6: 62. PMID 16539699 DOI: 10.1186/1471-2407-6-62  0.01
2006 Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. Plos Medicine. 3: e13. PMID 16318415 DOI: 10.1371/Journal.Pmed.0030013  0.01
2006 King CR, McNeal JE, Gill H, Brooks JD, Srinivas S, Presti JC. 1576: Reliability of Small Amounts of Cancer in Prostate Biopsies to Reveal True Pathologic Grade – Implications for Radiation Therapy Patients Journal of Urology. 175: 508-508. DOI: 10.1016/S0022-5347(18)33768-6  0.01
2006 Presti JC, McNeal JE, Hsu TH, Brooks JD, Gill H. 468: Performance of PSA Levels between 4 and 10 NG/ML in the Era of Extended Biopsy Schemes Journal of Urology. 175: 151-152. DOI: 10.1016/s0022-5347(18)32724-1  0.01
2006 Brooks JD. The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers Urologic Oncology: Seminars and Original Investigations. 24: 222-223. DOI: 10.1016/J.UROLONC.2005.11.018  0.01
2005 Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, van de Rijn M, Brooks JD, Pollack JR. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Research. 65: 8118-24. PMID 16166285 DOI: 10.1158/0008-5472.Can-04-4562  0.01
2005 Patel DA, Presti JC, McNeal JE, Gill H, Brooks JD, King CR. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy Journal of Clinical Oncology. 23: 6157-6162. PMID 16135482 DOI: 10.1200/JCO.2005.01.2336  0.01
2005 Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2237-43. PMID 15788672 DOI: 10.1158/1078-0432.Ccr-04-0356  0.01
2005 Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 596-604. PMID 15767336 DOI: 10.1158/1055-9965.EPI-04-0398  0.01
2005 Lee KL, Marotte JB, Ferrari MK, McNeal JE, Brooks JD, Presti JC. Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology. 65: 311-5. PMID 15708044 DOI: 10.1016/J.UROLOGY.2004.09.005  0.01
2005 Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Urology. 64: 749-53. PMID 15491714 DOI: 10.1016/J.UROLOGY.2004.04.070  0.01
2005 Zhao H, Kim Y, Wang P, Lapointe J, Tibshirani R, Pollack JR, Brooks JD. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. The Prostate. 63: 187-97. PMID 15486987 DOI: 10.1002/Pros.20158  0.01
2005 Zhao H, Lai F, Nonn L, Brooks JD, Peehl DM. Molecular targets of doxazosin in human prostatic stromal cells. The Prostate. 62: 400-10. PMID 15378519 DOI: 10.1002/Pros.20161  0.01
2005 Bhamre S, Vince P, Zhao H, Brooks JD. 401: Mechanisms of Action of Sulforaphane: A Putitutive Prostate Cancer Preventive Agent The Journal of Urology. 173: 110-110. DOI: 10.1016/S0022-5347(18)34654-8  0.01
2005 Zhao H, Brooks JD. 399: Different Effects of Methylseleninic Acid and Selenomethionine on the Transcriptional Programs of Prostate Cancer Cells The Journal of Urology. 173: 109-109. DOI: 10.1016/S0022-5347(18)34652-4  0.01
2005 Zhao H, Bair E, Tibshirani R, Ljungberg B, Brooks JD. 372: Identification of Molecular Subtypes and Prognostic Markers in Renal Cell Carcinomas Using CDNA Microarray Journal of Urology. 173: 102-102. DOI: 10.1016/S0022-5347(18)34625-1  0.01
2005 King C, Patel D, McNeal J, Gill H, Brooks J, Presti J. Preoperative PSA Velocity Predicts for Relapse After Radical Prostatectomy International Journal of Radiation Oncology*Biology*Physics. 63: S293. DOI: 10.1016/J.IJROBP.2005.07.500  0.01
2004 Rodwell GE, Sonu R, Zahn JM, Lund J, Wilhelmy J, Wang L, Xiao W, Mindrinos M, Crane E, Segal E, Myers BD, Brooks JD, Davis RW, Higgins J, Owen AB, et al. A transcriptional profile of aging in the human kidney. Plos Biology. 2: e427. PMID 15562319 DOI: 10.1371/Journal.Pbio.0020427  0.01
2004 Peehl DM, Shinghal R, Nonn L, Seto E, Krishnan AV, Brooks JD, Feldman D. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. The Journal of Steroid Biochemistry and Molecular Biology. 92: 131-41. PMID 15555907 DOI: 10.1016/J.Jsbmb.2004.07.003  0.01
2004 Marotte JB, Ferrari MK, McNeal JE, Brooks JD, Presti JC. Time trends in pathologic features of radical prostatectomy--impact of family history. Urologic Oncology. 22: 169-73. PMID 15271309 DOI: 10.1016/J.UROLONC.2004.04.003  0.01
2004 King CR, Presti JC, Gill H, Brooks J, Hancock SL. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? International Journal of Radiation Oncology, Biology, Physics. 59: 341-7. PMID 15145146 DOI: 10.1016/J.IJROBP.2003.10.015  0.01
2004 Presti JC, Lee U, Brooks JD, Terris MK. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. The Journal of Urology. 171: 2199-202. PMID 15126785 DOI: 10.1097/01.JU.0000124847.82541.60  0.01
2004 Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. The Prostate. 59: 243-51. PMID 15042599 DOI: 10.1002/PROS.20006  0.01
2004 Chao DH, Higgins JP, Brooks JD. Biochemical remission after resection of prostate cancer lung metastasis. Urology. 63: 584-5. PMID 15028469 DOI: 10.1016/J.UROLOGY.2003.10.069  0.01
2004 Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, ... Brooks JD, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 101: 811-6. PMID 14711987 DOI: 10.1073/Pnas.0304146101  0.01
2004 Higgins JP, Wang L, Kambham N, Montgomery K, Mason V, Vogelmann SU, Lemley KV, Brown PO, Brooks JD, van de Rijn M. Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Molecular Biology of the Cell. 15: 649-56. PMID 14657249 DOI: 10.1091/Mbc.E03-06-0432  0.01
2004 Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Molecular Biology of the Cell. 15: 506-19. PMID 14617803 DOI: 10.1091/Mbc.E03-07-0501  0.01
2004 Bebermeier J, DePrimo S, Brooks J, Hiort O, Holterhus P. Microarray-analysis of global androgen receptor co-regulator expression patterns in cultures derived from human urogenital tissues Experimental and Clinical Endocrinology & Diabetes. 112. DOI: 10.1055/s-2004-819051  0.01
2004 Ferrari MK, Malhotra SM, McNeal JE, Brooks JD. 842: Prognostic Significance of Vascular Invasion: A Long-Term Follow-Up of 621 Radical Prostatectomy Patients Journal of Urology. 171: 222-222. DOI: 10.1016/s0022-5347(18)38091-1  0.01
2003 Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proceedings of the National Academy of Sciences of the United States of America. 100: 13350-5. PMID 14595015 DOI: 10.1073/Pnas.2235735100  0.01
2003 Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD. Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biology. 4: R37. PMID 12801411 DOI: 10.1186/Gb-2003-4-6-R37  0.01
2003 Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. The American Journal of Pathology. 162: 925-32. PMID 12598325 DOI: 10.1016/S0002-9440(10)63887-4  0.01
2003 Shinghal R, Yemoto C, McNeal JE, Brooks JD. Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. Prostate-specific antigen. Urology. 61: 380-5. PMID 12597952 DOI: 10.1016/S0090-4295(02)02254-9  0.01
2003 Higgins JP, Montgomery K, Wang L, Domanay E, Warnke RA, Brooks JD, van de Rijn M. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays. The American Journal of Surgical Pathology. 27: 58-64. PMID 12502928 DOI: 10.1097/00000478-200301000-00007  0.01
2002 Shibata A, Garcia MI, Cheng I, Stamey TA, McNeal JE, Brooks JD, Henderson S, Yemoto CE, Peehl DM. Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. The Prostate. 52: 269-78. PMID 12210487 DOI: 10.1002/pros.10119  0.01
2002 DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biology. 3: RESEARCH0032. PMID 12184806 DOI: 10.1186/Gb-2002-3-7-Research0032  0.01
2002 Brooks JD. Microarray analysis in prostate cancer research. Current Opinion in Urology. 12: 395-9. PMID 12172426 DOI: 10.1097/00042307-200209000-00005  0.01
2002 Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells. The Prostate. 51: 225-30. PMID 11987150 DOI: 10.1002/pros.10093  0.01
2002 Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD, Jarrard DF. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. The Journal of Biological Chemistry. 277: 14877-83. PMID 11836256 DOI: 10.1074/Jbc.M200373200  0.01
2001 Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Annals of the New York Academy of Sciences. 952: 135-44. PMID 11795433 DOI: 10.1111/J.1749-6632.2001.Tb02734.X  0.01
2001 Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, Van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, Deweese TL, De Marzo AM, et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells American Journal of Pathology. 159: 1815-1826. PMID 11696442 DOI: 10.1016/S0002-9440(10)63028-3  0.01
2001 DePrimo SE, Shinghal R, Vidanes G, Brooks JD. Prevention of prostate cancer Hematology/Oncology Clinics of North America. 15: 445-457. PMID 11525290 DOI: 10.1016/S0889-8588(05)70225-2  0.01
2001 McNeal JE, Cohen RJ, Brooks JD. Role of cytologic criteria in the histologic diagnosis of Gleason grade 1 prostatic adenocarcinoma. Human Pathology. 32: 441-6. PMID 11331962 DOI: 10.1053/HUPA.2001.23521  0.01
2001 Williams ED, Brooks JD. New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents. Urology. 57: 100-2. PMID 11295605 DOI: 10.1016/S0090-4295(00)00951-1  0.01
2001 BROOKS JD, METTER E, CHAN DW, SOKOLL LJ, LANDIS P, NELSON WG, MULLER D, ANDRES R, CARTER H. PLASMA SELENIUM LEVEL BEFORE DIAGNOSIS AND THE RISK OF PROSTATE CANCER DEVELOPMENT Journal of Urology. 166: 2034-2038. DOI: 10.1016/S0022-5347(05)65500-0  0.01
2000 Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. International Journal of Oncology. 16: 663-76. PMID 10717233 DOI: 10.3892/Ijo.16.4.663  0.01
1997 Jacobs LB, Brooks JD, Epstein JI. Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder. Human Pathology. 28: 1152-7. PMID 9343322 DOI: 10.1016/S0046-8177(97)90253-7  0.01
1995 Brooks JD, Bova GS, Isaacs WB. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. The Prostate. 26: 35-9. PMID 7845865 DOI: 10.1002/Pros.2990260108  0.01
1995 Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM. Genetic alterations in prostate cancer. Cold Spring Harbor Symposia On Quantitative Biology. 59: 653-9. PMID 7587126 DOI: 10.1101/Sqb.1994.059.01.075  0.01
1995 Schoenberg M, Cairns P, Brooks JD, Marshall FF, Epstein JI, Isaacs WB, Sidransky D. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes, Chromosomes & Cancer. 12: 76-80. PMID 7534117 DOI: 10.1002/Gcc.2870120115  0.01
1995 Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM. Molecular genetics and chromosomal alterations in prostate cancer Cancer. 75: 2004-2012. DOI: 10.1002/1097-0142(19950401)75:7+<2004::Aid-Cncr2820751642>3.0.Co;2-Q  0.01
1994 Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 91: 11733-7. PMID 7972132 DOI: 10.1073/Pnas.91.24.11733  0.01
1993 Brooks JD, Bova GS, Marshall FF, Isaacs WB. Tumor suppressor gene allelic loss in human renal cancers. The Journal of Urology. 150: 1278-83. PMID 8371415 DOI: 10.1016/S0022-5347(17)35760-9  0.01
1993 Steiner MS, Burnett AL, Brooks JD, Brendler CB, Stutzman RE, Carter HB. Tubularized neourethra following radical retropubic prostatectomy. The Journal of Urology. 150: 407-9; discussion 40. PMID 8326564 DOI: 10.1016/S0022-5347(17)35494-0  0.01
1974 McLaughlin AP, Brooks JD. A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients. The Journal of Urology. 112: 366-72. PMID 4546711 DOI: 10.1016/S0022-5347(17)59733-5  0.01
Hide low-probability matches.